BeiGene Ltd. (BGNE) NASDAQ
$129.52 (2.44) (-1.85%)
Market Cap: $12.62B
As of 04/19/24 04:00 PM EDT. Market closed.
BeiGene Ltd. (BGNE)
NASDAQ
$129.52
(2.44) (-1.85%)
Market Cap: $12.62B
As of 04/19/24 04:00 PM EDT. Market closed.
Add to Portfolio
BeiGene is a biotechnology company that specializes in the development of drugs for cancer treatment. BeiGene has developed several pharmaceuticals, including tislelizumab, a checkpoint inhibitor, and ... read more
BeiGene is a biotechnology company that specializes in the development of drugs for cancer treatment. BeiGene has developed several pharmaceuticals, including tislelizumab, a checkpoint inhibitor, and zanubrutinib. read less
COMPANY PROFILE
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
CEO
John Oyler
Full Time Employees
5,300
URL
Address
No. 30 Science Park Road, Zhong-Guan-Cun Life Science Park, Beijing, Changping District, BEIJING.
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
CEO
John Oyler
Full Time Employees
5,300
URL
Address
No. 30 Science Park Road, Zhong-Guan-Cun Life Science Park, Beijing, Changping District, BEIJING.
PRICE CHART FOR BEIGENE LTD
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$129.48
Previous Close
$131.96
Days Range
$126.97 - $130.85
52 week range
$131.28 - $266.67
Volume
296,412
Avg. Volume (30 days)
163,506
Market Cap
$12.62B
Dividend Yield
-
P/E
(14.31)
Shares Outstanding
95,639,914
Open
$129.48
Previous Close
$131.96
Days Range
$126.97 - $130.85
52 week range
$131.28 - $266.67
Volume
296,412
Avg. Volume (30 days)
163,506
Market Cap
$12.62B
Dividend Yield
-
P/E
(14.31)
Shares Outstanding
95,639,914
FINANCIAL STATEMENTS FOR BEIGENE LTD
LOADING...
Open in: 
Open in:
INSIDER TRANSACTIONS FOR BEIGENE LTD
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| OYLER JOHN | Chief Executive Officer | Apr 11, 2024 | Sale | $146.73 | 12,084 | 1,773,085 | 7,076 | Apr 11, 2024, 06:01 PM |
| OYLER JOHN | Chief Executive Officer | Apr 10, 2024 | Sale | $148.89 | 26,716 | 3,977,861 | 27,286 | Apr 11, 2024, 06:01 PM |
| OYLER JOHN | Chief Executive Officer | Apr 09, 2024 | Sale | $153.94 | 11,200 | 1,724,078 | 49,458 | Apr 11, 2024, 06:01 PM |
| OYLER JOHN | Chief Executive Officer | Mar 13, 2024 | Sale | $177.56 | 12,332 | 2,189,648 | 9,595 | Mar 14, 2024, 05:23 PM |
| OYLER JOHN | Chief Executive Officer | Mar 12, 2024 | Sale | $164.02 | 37,668 | 6,178,369 | 43,402 | Mar 14, 2024, 05:23 PM |
| Wang Julia Aijun | Chief Financial Officer | Feb 29, 2024 | Sale | $167.08 | 397 | 66,331 | 0 | Mar 04, 2024, 05:22 PM |
| BAKER BROS. ADVISORS LP | Director | Nov 14, 2023 | Sale | $180.50 | 1,100,000 | 198,550,000 | 9,691,294 | Nov 14, 2023, 05:54 PM |
| Lee Chan Henry | SVP, General Counsel | Jul 31, 2023 | Sale | $216.26 | 791 | 171,059 | 0 | Aug 02, 2023, 05:10 PM |
| Wang Julia Aijun | Chief Financial Officer | Jul 03, 2023 | Sale | $179.55 | 472 | 84,747 | 0 | Jul 06, 2023, 05:02 PM |
| Wang Lai | Global Head of R&D | Jun 26, 2023 | Sale | $181.92 | 1,108 | 201,567 | 5 | Jun 27, 2023, 05:24 PM |
| Wang Julia Aijun | Chief Financial Officer | Jun 23, 2023 | Sale | $182.85 | 840 | 153,594 | 0 | Jun 27, 2023, 05:22 PM |
| Sanders Corazon (Corsee) D. | Director | Jun 23, 2023 | Sale | $182.32 | 578 | 105,381 | 478 | Jun 27, 2023, 05:21 PM |
| Wu Xiaobin | President, COO & GM China | Jun 26, 2023 | Sale | $182.37 | 1,495 | 272,636 | 0 | Jun 27, 2023, 05:20 PM |
| Wang Lai | Global Head of R&D | Jun 20, 2023 | Sale | $192.42 | 1,325 | 254,955 | 0 | Jun 20, 2023, 06:53 PM |
| HHLR ADVISORS, LTD. | 10% Owner | Jun 14, 2023 | Sale | $207.72 | 273,728 | 56,857,987 | 142,888,241 | Jun 15, 2023, 07:25 PM |
| HHLR ADVISORS, LTD. | 10% Owner | Jun 13, 2023 | Sale | $183.31 | 924,400 | 169,448,350 | 143,475,369 | Jun 15, 2023, 07:25 PM |
| HHLR ADVISORS, LTD. | 10% Owner | Jun 08, 2023 | Sale | $218.14 | 1,163,825 | 253,881,793 | 145,879,233 | Jun 12, 2023, 09:57 PM |
| HHLR ADVISORS, LTD. | 10% Owner | Jun 12, 2023 | Sale | $195.21 | 1,250,212 | 244,057,184 | 145,055,181 | Jun 12, 2023, 09:57 PM |
| HHLR ADVISORS, LTD. | 10% Owner | Jun 09, 2023 | Sale | $182.89 | 542,652 | 99,244,888 | 145,665,533 | Jun 12, 2023, 09:57 PM |
| Wang Lai | Global Head of R&D | Jun 07, 2023 | Sale | $224.74 | 462 | 103,828 | 388 | Jun 09, 2023, 05:46 PM |
| Wu Xiaobin | President, COO & GM China | Jun 07, 2023 | Sale | $224.73 | 3,291 | 739,599 | 2,760 | Jun 09, 2023, 05:44 PM |
| Wu Xiaobin | President, COO & GM China | May 08, 2023 | Sale | $253.72 | 7,000 | 1,776,037 | 0 | May 10, 2023, 04:44 PM |
| Wang Xiaodong | Director | Mar 08, 2023 | Option Exercise | $0.13 | 67,635 | 8,793 | 67,635 | Mar 10, 2023, 06:48 PM |
| Wang Xiaodong | Director | Mar 08, 2023 | Sale | $226.03 | 67,635 | 15,287,339 | 64,202 | Mar 10, 2023, 06:48 PM |
| Wang Xiaodong | Director | Jan 12, 2023 | Sale | $260.52 | 5,000 | 1,302,585 | 901 | Jan 17, 2023, 05:13 PM |
| OYLER JOHN | Chief Executive Officer | Jan 10, 2023 | Sale | $248.51 | 13,594 | 3,378,292 | 5,918 | Jan 12, 2023, 04:52 PM |
| OYLER JOHN | Chief Executive Officer | Jan 10, 2023 | Sale | $248.52 | 6,797 | 1,689,157 | 5,918 | Jan 12, 2023, 04:52 PM |
| Wang Xiaodong | Director | Jan 11, 2023 | Sale | $252.66 | 2,500 | 631,647 | 2,300 | Jan 11, 2023, 04:50 PM |
| Wang Xiaodong | Director | Jan 10, 2023 | Sale | $250.09 | 1,600 | 400,152 | 0 | Jan 11, 2023, 04:50 PM |
| Wang Xiaodong | Director | Jan 09, 2023 | Sale | $250.00 | 900 | 225,000 | 0 | Jan 11, 2023, 04:50 PM |
| OYLER JOHN | Chief Executive Officer | Dec 29, 2022 | Sale | $224.46 | 1,716 | 385,174 | 91 | Dec 29, 2022, 06:24 PM |
| OYLER JOHN | Chief Executive Officer | Dec 28, 2022 | Sale | $224.73 | 733 | 164,724 | 0 | Dec 29, 2022, 06:24 PM |
| OYLER JOHN | Chief Executive Officer | Dec 28, 2022 | Sale | $224.73 | 367 | 82,474 | 0 | Dec 29, 2022, 06:24 PM |
| OYLER JOHN | Chief Executive Officer | Dec 27, 2022 | Sale | $224.29 | 2,239 | 502,193 | 0 | Dec 29, 2022, 06:24 PM |
| OYLER JOHN | Chief Executive Officer | Dec 27, 2022 | Sale | $224.29 | 1,120 | 251,209 | 0 | Dec 29, 2022, 06:24 PM |
| OYLER JOHN | Chief Executive Officer | Dec 29, 2022 | Sale | $224.46 | 3,434 | 770,798 | 92 | Dec 29, 2022, 06:24 PM |
| Wang Xiaodong | Director | Dec 13, 2022 | Sale | $211.33 | 3,013 | 636,724 | 1,621 | Dec 15, 2022, 05:04 PM |
| Wang Xiaodong | Director | Nov 15, 2022 | Sale | $210.14 | 1,987 | 417,542 | 0 | Nov 17, 2022, 05:13 PM |
| OYLER JOHN | Chief Executive Officer | Nov 15, 2022 | Sale | $206.82 | 4,928 | 1,019,229 | 4,228 | Nov 17, 2022, 05:10 PM |
| OYLER JOHN | Chief Executive Officer | Nov 15, 2022 | Sale | $206.84 | 25,000 | 5,171,104 | 23,600 | Nov 17, 2022, 05:10 PM |
| OYLER JOHN | Chief Executive Officer | Sep 21, 2022 | Sale | $149.99 | 19,480 | 2,921,712 | 7,740 | Sep 22, 2022, 05:34 PM |
| OYLER JOHN | Chief Executive Officer | Sep 20, 2022 | Sale | $153.50 | 30,520 | 4,684,837 | 5,512 | Sep 22, 2022, 05:34 PM |
| Wang Xiaodong | Director | Aug 05, 2022 | Sale | $193.85 | 5,000 | 969,272 | 4,700 | Aug 09, 2022, 07:00 PM |
| Wang Xiaodong | Director | Aug 08, 2022 | Sale | $201.25 | 6,060 | 1,219,594 | 3,086 | Aug 09, 2022, 07:00 PM |
| Wang Xiaodong | Director | Aug 05, 2022 | Sale | $193.85 | 5,000 | 969,256 | 4,700 | Aug 09, 2022, 07:00 PM |
| Wang Julia Aijun | Chief Financial Officer | Jul 01, 2022 | Sale | $158.50 | 317 | 50,245 | 0 | Jul 18, 2022, 05:22 PM |
| Wang Julia Aijun | Chief Financial Officer | Jul 01, 2022 | Sale | $158.50 | 295 | 46,758 | 0 | Jul 05, 2022, 05:29 PM |
| Wang Lai | Global Head of R&D | Jun 27, 2022 | Sale | $177.32 | 458 | 81,215 | 0 | Jun 28, 2022, 05:32 PM |
| Wang Lai | Global Head of R&D | Jun 21, 2022 | Sale | $149.01 | 723 | 107,734 | 0 | Jun 22, 2022, 05:47 PM |
| Wang Lai | Global Head of R&D | Jun 17, 2022 | Sale | $139.40 | 445 | 62,034 | 723 | Jun 22, 2022, 05:47 PM |
| Wu Xiaobin | President, COO & GM China | Jun 21, 2022 | Sale | $144.36 | 1,010 | 145,804 | 0 | Jun 22, 2022, 05:45 PM |
| Wu Xiaobin | President, COO & GM China | Jun 17, 2022 | Sale | $139.60 | 578 | 80,691 | 1,010 | Jun 22, 2022, 05:45 PM |
| Wang Julia Aijun | Chief Financial Officer | Jun 17, 2022 | Sale | $136.64 | 161 | 21,999 | 0 | Jun 21, 2022, 05:09 PM |
| Wang Lai | Global Head of R&D | Jun 06, 2022 | Sale | $142.00 | 660 | 93,717 | 0 | Jun 08, 2022, 05:43 PM |
| Wu Xiaobin | President, COO & GM China | Jun 06, 2022 | Sale | $141.99 | 3,410 | 484,203 | 0 | Jun 08, 2022, 05:42 PM |
| Wang Lai | Global Head of R&D | May 17, 2022 | Option Exercise | $3.26 | 1,233,947 | 4,025,737 | 1,408,498 | May 19, 2022, 04:39 PM |
| Wu Xiaobin | President, COO & GM China | May 05, 2022 | Sale | $164.35 | 6,725 | 1,105,275 | 5,925 | May 06, 2022, 05:15 PM |
| Huang Jane | CMO, Hematology | Dec 14, 2021 | Option Exercise | $119.96 | 1,500 | 179,940 | 1,500 | Dec 16, 2021, 05:50 PM |
| Huang Jane | CMO, Hematology | Dec 14, 2021 | Sale | $278.14 | 1,500 | 417,211 | 1,200 | Dec 16, 2021, 05:50 PM |
| Huang Jane | CMO, Hematology | Dec 01, 2021 | Sale | $359.86 | 1,049 | 377,493 | 519 | Dec 02, 2021, 06:21 PM |
| Huang Jane | CMO, Hematology | Nov 17, 2021 | Option Exercise | $119.96 | 1,500 | 179,940 | 1,500 | Nov 19, 2021, 06:18 PM |
| Huang Jane | CMO, Hematology | Nov 17, 2021 | Sale | $381.34 | 1,500 | 572,003 | 1,300 | Nov 19, 2021, 06:18 PM |
| Wang Xiaodong | Director | Nov 08, 2021 | Sale | $350.04 | 4,500 | 1,575,202 | 4,100 | Nov 10, 2021, 05:30 PM |
| Wang Xiaodong | Director | Nov 08, 2021 | Sale | $349.81 | 4,500 | 1,574,148 | 4,200 | Nov 10, 2021, 05:25 PM |
| Wu Xiaobin | President, COO & GM China | Nov 09, 2021 | Sale | $366.34 | 2,334 | 855,038 | 2,034 | Nov 10, 2021, 05:14 PM |
| Wu Xiaobin | President, COO & GM China | Nov 08, 2021 | Sale | $355.81 | 7,666 | 2,727,625 | 7,366 | Nov 10, 2021, 05:14 PM |
| Huang Jane | CMO, Hematology | Oct 19, 2021 | Option Exercise | $119.96 | 1,500 | 179,940 | 1,500 | Oct 21, 2021, 05:37 PM |
| Huang Jane | CMO, Hematology | Oct 19, 2021 | Sale | $372.78 | 1,500 | 559,163 | 1,300 | Oct 21, 2021, 05:37 PM |
| Huang Jane | CMO, Hematology | Sep 20, 2021 | Option Exercise | $119.96 | 6,000 | 719,760 | 6,000 | Sep 22, 2021, 06:15 PM |
| Huang Jane | CMO, Hematology | Sep 20, 2021 | Sale | $397.96 | 6,000 | 2,387,774 | 5,900 | Sep 22, 2021, 06:15 PM |
| OYLER JOHN | Chief Executive Officer | Sep 15, 2021 | Sale | $71.36 | 216,361 | 15,439,460 | 1,736,904 | Sep 16, 2021, 06:06 PM |
| OYLER JOHN | Chief Executive Officer | Sep 14, 2021 | Sale | $93.87 | 195,477 | 18,348,858 | 2,267,161 | Sep 16, 2021, 06:06 PM |
| Huang Jane | CMO, Hematology | Sep 13, 2021 | Sale | $358.14 | 12,901 | 4,620,392 | 8,682 | Sep 15, 2021, 06:16 PM |
| AMGEN INC | 10% Owner | Sep 10, 2021 | Buy | $302.06 | 165,529 | 49,999,856 | 18,943,802 | Sep 13, 2021, 07:27 PM |
| OYLER JOHN | Chief Executive Officer | Sep 02, 2021 | Sale | $328.21 | 24,499 | 8,040,809 | 20,099 | Sep 02, 2021, 08:40 PM |
| OYLER JOHN | Chief Executive Officer | Sep 01, 2021 | Sale | $74.56 | 153,059 | 11,411,639 | 3,567,562 | Sep 02, 2021, 08:40 PM |
| OYLER JOHN | Chief Executive Officer | Aug 31, 2021 | Sale | $110.13 | 111,081 | 12,232,867 | 3,694,720 | Sep 02, 2021, 08:40 PM |
| Huang Jane | CMO, Hematology | Sep 02, 2021 | Sale | $327.18 | 545 | 178,314 | 0 | Sep 02, 2021, 08:39 PM |
| Huang Jane | CMO, Hematology | Sep 01, 2021 | Sale | $310.53 | 542 | 168,307 | 0 | Sep 02, 2021, 08:39 PM |
| OYLER JOHN | Chief Executive Officer | Aug 05, 2021 | Sale | $98.47 | 44,462 | 4,378,046 | 4,217,173 | Aug 05, 2021, 09:03 PM |
| OYLER JOHN | Chief Executive Officer | Aug 04, 2021 | Sale | $150.97 | 80,847 | 12,205,592 | 4,385,979 | Aug 05, 2021, 09:03 PM |
| OYLER JOHN | Chief Executive Officer | Aug 03, 2021 | Sale | $182.37 | 83,359 | 15,202,040 | 4,847,790 | Aug 05, 2021, 09:01 PM |
| OYLER JOHN | Chief Executive Officer | Jul 22, 2021 | Sale | $71.82 | 69,216 | 4,971,359 | 5,434,657 | Jul 22, 2021, 06:23 PM |
| OYLER JOHN | Chief Executive Officer | Jul 21, 2021 | Sale | $184.09 | 27,160 | 4,999,824 | 5,639,665 | Jul 22, 2021, 06:21 PM |
| OYLER JOHN | Chief Executive Officer | Jul 20, 2021 | Sale | $132.26 | 43,695 | 5,779,054 | 5,849,945 | Jul 22, 2021, 06:21 PM |
| Huang Jane | CMO, Hematology | Jul 15, 2021 | Option Exercise | $146.90 | 21,000 | 3,085,002 | 21,000 | Jul 19, 2021, 04:43 PM |
| Huang Jane | CMO, Hematology | Jul 15, 2021 | Sale | $332.42 | 21,000 | 6,980,771 | 18,621 | Jul 19, 2021, 04:43 PM |
| OYLER JOHN | Chief Executive Officer | Jul 07, 2021 | Sale | $325.23 | 300 | 97,570 | 0 | Jul 08, 2021, 07:11 PM |
| OYLER JOHN | Chief Executive Officer | Jul 08, 2021 | Sale | $93.80 | 67,181 | 6,301,730 | 6,085,580 | Jul 08, 2021, 07:11 PM |
| OYLER JOHN | Chief Executive Officer | Jul 07, 2021 | Sale | $137.54 | 66,446 | 9,139,023 | 6,343,333 | Jul 08, 2021, 07:09 PM |
| OYLER JOHN | Chief Executive Officer | Jul 06, 2021 | Sale | $93.69 | 57,375 | 5,375,612 | 6,722,631 | Jul 08, 2021, 07:09 PM |
| Wu Xiaobin | President, COO & GM China | Jul 06, 2021 | Sale | $325.53 | 10,180 | 3,313,928 | 9,780 | Jul 08, 2021, 06:25 PM |
| Wang Xiaodong | Director | Jul 01, 2021 | Sale | $348.15 | 4,848 | 1,687,852 | 4,548 | Jul 01, 2021, 06:01 PM |
| Wang Julia Aijun | Chief Financial Officer | Jul 01, 2021 | Sale | $349.06 | 308 | 107,512 | 0 | Jul 01, 2021, 04:58 PM |
| Huang Jane | CMO, Hematology | Jun 29, 2021 | Option Exercise | $29.49 | 1,500 | 44,235 | 1,500 | Jun 30, 2021, 04:49 PM |
| Huang Jane | CMO, Hematology | Jun 29, 2021 | Sale | $352.13 | 1,500 | 528,198 | 1,200 | Jun 30, 2021, 04:49 PM |
| Huang Jane | CMO, Hematology | Jun 28, 2021 | Sale | $365.00 | 425 | 155,125 | 0 | Jun 30, 2021, 04:49 PM |
| Wang Lai | Global Head of R&D | Jun 28, 2021 | Sale | $362.48 | 455 | 164,930 | 0 | Jun 30, 2021, 04:48 PM |
| Liang Howard | CFO & Chief Strategy Officer | Jun 28, 2021 | Sale | $365.00 | 446 | 162,790 | 0 | Jun 30, 2021, 04:45 PM |
| Huang Jane | CMO, Hematology | Jun 18, 2021 | Sale | $325.66 | 469 | 152,733 | 0 | Jun 21, 2021, 04:45 PM |
| Chen Timothy Yung-Cheng | Director | Jun 09, 2021 | Option Exercise | $31.59 | 3,164 | 99,951 | 3,164 | Jun 11, 2021, 04:36 PM |
| Chen Timothy Yung-Cheng | Director | Jun 10, 2021 | Option Exercise | $31.59 | 2,836 | 89,589 | 2,836 | Jun 11, 2021, 04:36 PM |
| Chen Timothy Yung-Cheng | Director | Jun 09, 2021 | Sale | $351.35 | 3,164 | 1,111,669 | 1,801 | Jun 11, 2021, 04:36 PM |
| Chen Timothy Yung-Cheng | Director | Jun 10, 2021 | Sale | $352.03 | 2,836 | 998,348 | 2,152 | Jun 11, 2021, 04:36 PM |
| Wu Xiaobin | President, COO & GM China | Jun 07, 2021 | Sale | $352.54 | 3,398 | 1,197,918 | 573 | Jun 09, 2021, 04:49 PM |
| Huang Jane | CMO, Hematology | Jun 07, 2021 | Sale | $351.55 | 603 | 211,986 | 0 | Jun 09, 2021, 04:45 PM |
| Wang Xiaodong | Director | May 10, 2021 | Option Exercise | $0.13 | 47,503 | 6,175 | 5,747,271 | May 12, 2021, 04:32 PM |
| Wang Xiaodong | Director | May 10, 2021 | Sale | $300.46 | 3,394 | 1,019,751 | 2,294 | May 12, 2021, 04:32 PM |
| Huang Jane | CMO, Hematology | Apr 29, 2021 | Option Exercise | $29.49 | 1,500 | 44,235 | 1,500 | May 03, 2021, 04:35 PM |
| Huang Jane | CMO, Hematology | Apr 29, 2021 | Sale | $354.92 | 1,500 | 532,387 | 1,400 | May 03, 2021, 04:35 PM |
| Huang Jane | CMO, Hematology | Mar 29, 2021 | Option Exercise | $29.49 | 1,500 | 44,235 | 1,500 | Mar 31, 2021, 04:46 PM |
| Huang Jane | CMO, Hematology | Mar 29, 2021 | Sale | $324.00 | 1,500 | 485,993 | 1,200 | Mar 31, 2021, 04:46 PM |
| Huang Jane | CMO, Hematology | Feb 26, 2021 | Option Exercise | $29.49 | 1,500 | 44,235 | 1,500 | Mar 02, 2021, 04:52 PM |
| Huang Jane | CMO, Hematology | Feb 26, 2021 | Sale | $320.73 | 1,500 | 481,099 | 1,400 | Mar 02, 2021, 04:52 PM |
| Huang Jane | CMO, Hematology | Jan 29, 2021 | Option Exercise | $29.49 | 1,500 | 44,235 | 1,500 | Feb 02, 2021, 04:49 PM |
| Huang Jane | CMO, Hematology | Jan 29, 2021 | Sale | $322.99 | 1,500 | 484,492 | 1,200 | Feb 02, 2021, 04:49 PM |
| Liang Howard | CFO & Chief Strategy Officer | Jan 15, 2021 | Option Exercise | $6.50 | 12,600 | 81,900 | 12,600 | Jan 19, 2021, 05:04 PM |
| Liang Howard | CFO & Chief Strategy Officer | Jan 14, 2021 | Option Exercise | $6.50 | 1,400 | 9,100 | 1,400 | Jan 19, 2021, 05:04 PM |
| Liang Howard | CFO & Chief Strategy Officer | Jan 15, 2021 | Sale | $344.90 | 12,600 | 4,345,687 | 5,606 | Jan 19, 2021, 05:04 PM |
| Liang Howard | CFO & Chief Strategy Officer | Jan 14, 2021 | Sale | $344.47 | 1,400 | 482,256 | 300 | Jan 19, 2021, 05:04 PM |
| BAKER BROS. ADVISORS LP | Director | Jan 04, 2021 | Sale | $220.50 | 121,154 | 26,714,457 | 10,699,954 | Jan 06, 2021, 06:32 PM |
| Huang Jane | CMO, Hematology | Dec 29, 2020 | Option Exercise | $29.49 | 1,500 | 44,235 | 1,500 | Dec 30, 2020, 04:34 PM |
| Huang Jane | CMO, Hematology | Dec 29, 2020 | Sale | $249.13 | 1,500 | 373,690 | 1,300 | Dec 30, 2020, 04:34 PM |
| AMGEN INC | 10% Owner | Dec 18, 2020 | Option Exercise | $260.95 | 25,762 | 6,722,516 | 18,778,273 | Dec 18, 2020, 09:25 PM |
| AMGEN INC | 10% Owner | Dec 17, 2020 | Option Exercise | $260.54 | 74,624 | 19,442,538 | 18,752,511 | Dec 17, 2020, 09:18 PM |
| AMGEN INC | 10% Owner | Dec 16, 2020 | Option Exercise | $248.26 | 85,573 | 21,244,439 | 18,677,887 | Dec 17, 2020, 09:18 PM |
| AMGEN INC | 10% Owner | Dec 15, 2020 | Option Exercise | $239.31 | 67,941 | 16,258,757 | 18,592,314 | Dec 17, 2020, 09:18 PM |
| Liang Howard | CFO & Chief Strategy Officer | Dec 14, 2020 | Option Exercise | $0.87 | 1,497,200 | 1,300,000 | 1,573,715 | Dec 16, 2020, 04:43 PM |
| Liang Howard | CFO & Chief Strategy Officer | Dec 14, 2020 | Sale | $229.04 | 91,900 | 21,048,471 | 87,800 | Dec 16, 2020, 04:43 PM |
| BAKER BROS. ADVISORS LP | Director | Dec 04, 2020 | Sale | $220.50 | 1,511,546 | 333,295,893 | 10,811,048 | Dec 04, 2020, 05:24 PM |
| Huang Jane | CMO, Hematology | Nov 30, 2020 | Option Exercise | $29.49 | 1,500 | 44,235 | 1,500 | Dec 02, 2020, 05:01 PM |
| Huang Jane | CMO, Hematology | Nov 30, 2020 | Sale | $267.81 | 1,500 | 401,722 | 1,396 | Dec 02, 2020, 05:01 PM |
| Huang Jane | CMO, Hematology | Oct 29, 2020 | Option Exercise | $29.49 | 1,500 | 44,235 | 1,500 | Nov 02, 2020, 04:44 PM |
| Huang Jane | CMO, Hematology | Oct 29, 2020 | Sale | $300.06 | 1,500 | 450,092 | 239 | Nov 02, 2020, 04:44 PM |
| Wang Xiaodong | Director | Oct 16, 2020 | Sale | $320.00 | 5,000 | 1,600,000 | 0 | Oct 20, 2020, 04:44 PM |
| Wang Xiaodong | Director | Oct 05, 2020 | Sale | $300.00 | 5,000 | 1,500,000 | 0 | Oct 07, 2020, 04:56 PM |
| Wu Xiaobin | President & GM China | Oct 05, 2020 | Sale | $300.00 | 4,000 | 1,200,000 | 0 | Oct 07, 2020, 04:52 PM |
| Liang Howard | CFO & Chief Strategy Officer | Oct 05, 2020 | Option Exercise | $6.50 | 14,000 | 91,000 | 14,000 | Oct 07, 2020, 04:50 PM |
| Liang Howard | CFO & Chief Strategy Officer | Oct 05, 2020 | Sale | $299.60 | 14,000 | 4,194,415 | 13,183 | Oct 07, 2020, 04:50 PM |
| Huang Jane | CMO, Hematology | Sep 29, 2020 | Option Exercise | $29.49 | 1,500 | 44,235 | 1,500 | Oct 01, 2020, 04:52 PM |
| Huang Jane | CMO, Hematology | Sep 29, 2020 | Sale | $280.38 | 1,500 | 420,568 | 1,300 | Oct 01, 2020, 04:52 PM |
| OYLER JOHN | Chief Executive Officer | Sep 29, 2020 | Sale | $280.82 | 23,303 | 6,544,031 | 22,853 | Sep 30, 2020, 04:53 PM |
| OYLER JOHN | Chief Executive Officer | Sep 28, 2020 | Sale | $280.07 | 31,000 | 8,682,061 | 28,767 | Sep 30, 2020, 04:53 PM |
| Wang Xiaodong | Director | Sep 25, 2020 | Sale | $280.42 | 5,000 | 1,402,117 | 620 | Sep 29, 2020, 04:59 PM |
| Wu Xiaobin | President & GM China | Sep 25, 2020 | Sale | $280.35 | 4,000 | 1,121,408 | 0 | Sep 29, 2020, 04:57 PM |
| Wang Xiaodong | Director | Sep 17, 2020 | Sale | $260.27 | 5,000 | 1,301,358 | 84 | Sep 21, 2020, 04:53 PM |
| Wu Xiaobin | President & GM China | Sep 17, 2020 | Sale | $260.33 | 4,000 | 1,041,326 | 500 | Sep 21, 2020, 04:50 PM |
| OYLER JOHN | Chief Executive Officer | Sep 15, 2020 | Sale | $254.26 | 34,214 | 8,699,382 | 32,014 | Sep 16, 2020, 05:12 PM |
| OYLER JOHN | Chief Executive Officer | Sep 14, 2020 | Sale | $250.25 | 19,739 | 4,939,776 | 19,139 | Sep 16, 2020, 05:12 PM |
| OYLER JOHN | Chief Executive Officer | Sep 16, 2020 | Sale | $254.77 | 27,275 | 6,948,803 | 16,963 | Sep 16, 2020, 05:12 PM |
| Liang Howard | CFO & Chief Strategy Officer | Sep 14, 2020 | Option Exercise | $6.50 | 14,000 | 91,000 | 14,000 | Sep 16, 2020, 05:10 PM |
| Liang Howard | CFO & Chief Strategy Officer | Sep 14, 2020 | Sale | $250.27 | 14,000 | 3,503,765 | 13,600 | Sep 16, 2020, 05:10 PM |
| Huang Jane | CMO, Hematology | Sep 03, 2020 | Sale | $233.07 | 3,128 | 729,044 | 2,128 | Sep 08, 2020, 04:44 PM |
| OYLER JOHN | Chief Executive Officer | Sep 01, 2020 | Sale | $233.79 | 20,274 | 4,739,812 | 16,329 | Sep 02, 2020, 05:44 PM |
| OYLER JOHN | Chief Executive Officer | Aug 31, 2020 | Sale | $240.86 | 12,961 | 3,121,766 | 11,861 | Sep 02, 2020, 05:44 PM |
| OYLER JOHN | Chief Executive Officer | Sep 02, 2020 | Sale | $229.22 | 27,807 | 6,374,025 | 26,607 | Sep 02, 2020, 05:44 PM |
| Huang Jane | CMO, Hematology | Aug 28, 2020 | Option Exercise | $29.49 | 3,000 | 88,470 | 3,000 | Sep 01, 2020, 04:41 PM |
| Huang Jane | CMO, Hematology | Aug 28, 2020 | Sale | $242.21 | 3,000 | 726,627 | 2,200 | Sep 01, 2020, 04:41 PM |
| AMGEN INC | 10% Owner | Aug 25, 2020 | Option Exercise | $248.49 | 59,390 | 14,757,583 | 18,524,373 | Aug 25, 2020, 05:55 PM |
| AMGEN INC | 10% Owner | Aug 21, 2020 | Option Exercise | $230.18 | 64,176 | 14,772,031 | 18,405,593 | Aug 24, 2020, 05:47 PM |
| AMGEN INC | 10% Owner | Aug 24, 2020 | Option Exercise | $239.10 | 59,390 | 14,199,911 | 18,464,983 | Aug 24, 2020, 05:47 PM |
| OYLER JOHN | Chief Executive Officer | Aug 21, 2020 | Sale | $240.19 | 40,788 | 9,796,779 | 37,685 | Aug 21, 2020, 05:21 PM |
| OYLER JOHN | Chief Executive Officer | Aug 20, 2020 | Sale | $234.62 | 21,523 | 5,049,747 | 20,523 | Aug 21, 2020, 05:21 PM |
| OYLER JOHN | Chief Executive Officer | Aug 19, 2020 | Sale | $234.56 | 29,866 | 7,005,270 | 26,465 | Aug 21, 2020, 05:21 PM |
| AMGEN INC | 10% Owner | Aug 20, 2020 | Option Exercise | $234.99 | 64,176 | 15,080,975 | 18,341,417 | Aug 20, 2020, 07:28 PM |
| AMGEN INC | 10% Owner | Aug 19, 2020 | Option Exercise | $234.88 | 64,176 | 15,073,466 | 18,277,241 | Aug 20, 2020, 07:28 PM |
| AMGEN INC | 10% Owner | Aug 18, 2020 | Option Exercise | $230.18 | 40,000 | 9,207,200 | 18,213,065 | Aug 20, 2020, 07:28 PM |
| OYLER JOHN | Chief Executive Officer | Aug 14, 2020 | Sale | $211.15 | 8,705 | 1,838,037 | 6,407 | Aug 14, 2020, 05:30 PM |
| OYLER JOHN | Chief Executive Officer | Aug 13, 2020 | Sale | $214.48 | 14,443 | 3,097,763 | 13,762 | Aug 14, 2020, 05:30 PM |
| OYLER JOHN | Chief Executive Officer | Aug 12, 2020 | Sale | $212.10 | 19,820 | 4,203,769 | 18,720 | Aug 14, 2020, 05:30 PM |
| Chen Timothy Yung-Cheng | Director | Aug 11, 2020 | Option Exercise | $31.59 | 1,903 | 60,116 | 1,903 | Aug 12, 2020, 05:02 PM |
| Chen Timothy Yung-Cheng | Director | Aug 10, 2020 | Option Exercise | $31.59 | 2,200 | 69,498 | 2,200 | Aug 12, 2020, 05:02 PM |
| Chen Timothy Yung-Cheng | Director | Aug 12, 2020 | Option Exercise | $31.59 | 2,897 | 91,516 | 2,897 | Aug 12, 2020, 05:02 PM |
| Chen Timothy Yung-Cheng | Director | Aug 10, 2020 | Sale | $214.04 | 2,200 | 470,886 | 1,500 | Aug 12, 2020, 05:02 PM |
| Chen Timothy Yung-Cheng | Director | Aug 12, 2020 | Sale | $212.00 | 2,897 | 614,164 | 0 | Aug 12, 2020, 05:02 PM |
| Chen Timothy Yung-Cheng | Director | Aug 11, 2020 | Sale | $213.04 | 1,903 | 405,409 | 903 | Aug 12, 2020, 05:02 PM |
| Wang Xiaodong | Director | Aug 10, 2020 | Sale | $211.06 | 4,000 | 844,229 | 2,500 | Aug 12, 2020, 04:38 PM |
| OYLER JOHN | Chief Executive Officer | Aug 05, 2020 | Sale | $223.27 | 17,254 | 3,852,275 | 16,554 | Aug 05, 2020, 05:43 PM |
| OYLER JOHN | Chief Executive Officer | Aug 04, 2020 | Sale | $220.44 | 15,383 | 3,390,953 | 15,100 | Aug 05, 2020, 05:30 PM |
| OYLER JOHN | Chief Executive Officer | Aug 03, 2020 | Sale | $221.78 | 25,176 | 5,583,571 | 25,076 | Aug 05, 2020, 05:30 PM |
| Huang Jane | CMO, Hematology | Jul 29, 2020 | Option Exercise | $94.94 | 3,000 | 284,835 | 3,000 | Jul 31, 2020, 04:24 PM |
| Huang Jane | CMO, Hematology | Jul 29, 2020 | Sale | $209.93 | 3,000 | 629,787 | 1,699 | Jul 31, 2020, 04:24 PM |
| OYLER JOHN | Chief Executive Officer | Jul 22, 2020 | Sale | $238.34 | 27,748 | 6,613,501 | 21,612 | Jul 22, 2020, 06:22 PM |
| OYLER JOHN | Chief Executive Officer | Jul 21, 2020 | Sale | $251.83 | 26,413 | 6,651,693 | 22,003 | Jul 22, 2020, 06:14 PM |
| OYLER JOHN | Chief Executive Officer | Jul 20, 2020 | Sale | $251.85 | 28,762 | 7,243,786 | 28,062 | Jul 22, 2020, 06:14 PM |
| Wang Xiaodong | Director | Jul 20, 2020 | Sale | $251.98 | 5,000 | 1,259,896 | 4,700 | Jul 22, 2020, 04:47 PM |
| Wang Xiaodong | Director | Jul 20, 2020 | Sale | $251.31 | 12,000 | 3,015,742 | 11,500 | Jul 22, 2020, 04:47 PM |
| Wu Xiaobin | President & GM China | Jul 20, 2020 | Sale | $250.16 | 2,600 | 650,408 | 0 | Jul 21, 2020, 04:50 PM |
| Wu Xiaobin | President & GM China | Jul 17, 2020 | Sale | $245.74 | 700 | 172,015 | 400 | Jul 21, 2020, 04:50 PM |
| BAKER BROS. ADVISORS LP | Director | Jul 15, 2020 | Option Exercise | $14.23 | 14,584,180 | 207,544,544 | 18,840,379 | Jul 17, 2020, 05:23 PM |
| AMGEN INC | 10% Owner | Jul 15, 2020 | Option Exercise | $14.23 | 29,614,832 | 421,442,742 | 236,249,845 | Jul 16, 2020, 05:18 PM |
| Wu Xiaobin | President & GM China | Jul 13, 2020 | Sale | $220.00 | 3,000 | 660,000 | 0 | Jul 15, 2020, 05:14 PM |
| Wu Xiaobin | President & GM China | Jul 15, 2020 | Sale | $241.11 | 2,700 | 650,998 | 700 | Jul 15, 2020, 05:14 PM |
| Wang Xiaodong | Director | Jul 07, 2020 | Sale | $200.00 | 6,000 | 1,200,000 | 0 | Jul 09, 2020, 04:45 PM |
| Huang Jane | CMO, Hematology | Jul 07, 2020 | Option Exercise | $160.40 | 3,921 | 628,928 | 3,921 | Jul 09, 2020, 04:43 PM |
| Huang Jane | CMO, Hematology | Jul 07, 2020 | Sale | $200.00 | 3,921 | 784,200 | 0 | Jul 09, 2020, 04:43 PM |
| OYLER JOHN | Chief Executive Officer | Jul 08, 2020 | Sale | $201.39 | 17,529 | 3,530,204 | 16,929 | Jul 08, 2020, 05:20 PM |
| OYLER JOHN | Chief Executive Officer | Jul 07, 2020 | Sale | $198.86 | 19,023 | 3,782,991 | 15,293 | Jul 08, 2020, 05:20 PM |
| OYLER JOHN | Chief Executive Officer | Jul 06, 2020 | Sale | $197.11 | 17,362 | 3,422,258 | 16,562 | Jul 08, 2020, 05:20 PM |
| Wang Xiaodong | Director | Jul 01, 2020 | Sale | $190.75 | 4,847 | 924,572 | 4,157 | Jul 06, 2020, 04:52 PM |
| OYLER JOHN | Chief Executive Officer | Jul 01, 2020 | Sale | $191.57 | 3,816 | 731,017 | 1,800 | Jul 01, 2020, 04:43 PM |
| OYLER JOHN | Chief Executive Officer | Jun 29, 2020 | Sale | $192.60 | 1,435 | 276,374 | 1,135 | Jul 01, 2020, 04:43 PM |
| Liang Howard | CFO & Chief Strategy Officer | Jun 29, 2020 | Sale | $191.23 | 300 | 57,368 | 0 | Jul 01, 2020, 04:38 PM |
| Huang Jane | CMO, Hematology | Jun 26, 2020 | Option Exercise | $160.40 | 2,079 | 333,472 | 2,079 | Jun 30, 2020, 04:14 PM |
| Huang Jane | CMO, Hematology | Jun 29, 2020 | Option Exercise | $29.49 | 1,500 | 44,235 | 1,500 | Jun 30, 2020, 04:14 PM |
| Huang Jane | CMO, Hematology | Jun 29, 2020 | Sale | $190.83 | 1,935 | 369,250 | 1,200 | Jun 30, 2020, 04:14 PM |
| Huang Jane | CMO, Hematology | Jun 26, 2020 | Sale | $200.29 | 2,079 | 416,396 | 1,400 | Jun 30, 2020, 04:14 PM |
| OYLER JOHN | Chief Executive Officer | Jun 24, 2020 | Sale | $187.34 | 14,381 | 2,694,154 | 9,640 | Jun 24, 2020, 08:23 PM |
| OYLER JOHN | Chief Executive Officer | Jun 23, 2020 | Sale | $186.88 | 15,070 | 2,816,221 | 28,761 | Jun 24, 2020, 08:23 PM |
| OYLER JOHN | Chief Executive Officer | Jun 22, 2020 | Sale | $182.43 | 10,281 | 1,875,605 | 38,832 | Jun 24, 2020, 08:23 PM |
| Wang Xiaodong | Director | Jun 23, 2020 | Sale | $186.38 | 6,000 | 1,118,297 | 4,155 | Jun 24, 2020, 08:12 PM |
| Wang Xiaodong | Director | Jun 22, 2020 | Sale | $181.33 | 5,000 | 906,673 | 3,200 | Jun 24, 2020, 08:12 PM |
| OYLER JOHN | Chief Executive Officer | Jun 10, 2020 | Sale | $175.07 | 900 | 157,563 | 0 | Jun 12, 2020, 04:14 PM |
| Liang Howard | CFO & Chief Strategy Officer | Jun 08, 2020 | Sale | $170.84 | 453 | 77,391 | 0 | Jun 10, 2020, 05:17 PM |
| Wu Xiaobin | President & GM China | Jun 08, 2020 | Sale | $170.83 | 2,800 | 478,317 | 1,600 | Jun 10, 2020, 05:15 PM |
| Huang Jane | CMO, Hematology | Jun 08, 2020 | Sale | $170.84 | 631 | 107,800 | 0 | Jun 10, 2020, 05:13 PM |
| Wang Xiaodong | Director | Jun 08, 2020 | Sale | $170.91 | 6,000 | 1,025,456 | 2,500 | Jun 10, 2020, 05:12 PM |
| Huang Jane | CMO, Hematology | May 29, 2020 | Option Exercise | $29.49 | 1,500 | 44,235 | 1,500 | Jun 02, 2020, 04:11 PM |
| Huang Jane | CMO, Hematology | May 29, 2020 | Sale | $163.86 | 1,500 | 245,784 | 1,000 | Jun 02, 2020, 04:11 PM |
| Glazer Donald W. | Director | May 19, 2020 | Sale | $169.84 | 10,000 | 1,698,400 | 0 | May 21, 2020, 04:08 PM |
| OYLER JOHN | Chief Executive Officer | May 01, 2020 | Sale | $141.43 | 4,635 | 655,538 | 3,635 | May 05, 2020, 04:48 PM |
| Wu Xiaobin | President & GM China | May 01, 2020 | Sale | $141.33 | 7,024 | 992,711 | 1,769 | May 05, 2020, 04:46 PM |
| Huang Jane | CMO, Hematology | Apr 29, 2020 | Option Exercise | $29.49 | 1,500 | 44,235 | 1,500 | Apr 30, 2020, 04:04 PM |
| Huang Jane | CMO, Hematology | Apr 29, 2020 | Sale | $162.30 | 1,500 | 243,450 | 0 | Apr 30, 2020, 04:04 PM |
| Huang Jane | CMO, Hematology | Apr 16, 2020 | Option Exercise | $29.49 | 1,500 | 44,235 | 1,500 | Apr 17, 2020, 04:04 PM |
| Huang Jane | CMO, Hematology | Apr 16, 2020 | Sale | $160.00 | 1,500 | 240,000 | 0 | Apr 17, 2020, 04:04 PM |
| Wang Xiaodong | Director | Mar 04, 2020 | Sale | $157.14 | 5,000 | 785,682 | 1,969 | Mar 06, 2020, 08:30 PM |
| Huang Jane | CMO, Hematology | Feb 18, 2020 | Option Exercise | $29.49 | 1,500 | 44,235 | 1,500 | Feb 20, 2020, 04:13 PM |
| Huang Jane | CMO, Hematology | Feb 18, 2020 | Sale | $170.25 | 1,500 | 255,380 | 321 | Feb 20, 2020, 04:13 PM |
| Huang Jane | CMO, Hematology | Jan 21, 2020 | Option Exercise | $29.49 | 1,500 | 44,235 | 1,500 | Jan 22, 2020, 06:59 PM |
| Huang Jane | CMO, Hematology | Jan 21, 2020 | Sale | $170.70 | 1,500 | 256,043 | 687 | Jan 22, 2020, 06:59 PM |
| OYLER JOHN | Chief Executive Officer | Dec 17, 2019 | Sale | $160.62 | 62,259 | 10,000,110 | 55,204 | Dec 19, 2019, 04:10 PM |
| Huang Jane | CMO, Hematology | Dec 16, 2019 | Option Exercise | $29.49 | 1,500 | 44,235 | 1,500 | Dec 18, 2019, 06:57 PM |
| Huang Jane | CMO, Hematology | Dec 16, 2019 | Sale | $165.14 | 1,500 | 247,711 | 1,400 | Dec 18, 2019, 06:57 PM |
| Liang Howard | CFO & Chief Strategy Officer | Nov 18, 2019 | Option Exercise | $6.50 | 25,000 | 162,500 | 25,000 | Nov 20, 2019, 07:20 PM |
| Liang Howard | CFO & Chief Strategy Officer | Nov 18, 2019 | Sale | $194.34 | 25,000 | 4,858,612 | 23,844 | Nov 20, 2019, 07:20 PM |
| Huang Jane | CMO, Hematology | Nov 18, 2019 | Option Exercise | $29.49 | 1,500 | 44,235 | 1,500 | Nov 20, 2019, 07:19 PM |
| Huang Jane | CMO, Hematology | Nov 18, 2019 | Sale | $194.49 | 1,500 | 291,740 | 1,300 | Nov 20, 2019, 07:19 PM |
| Wang Xiaodong | Director | Nov 15, 2019 | Sale | $202.05 | 395 | 79,810 | 0 | Nov 18, 2019, 05:24 PM |
| Wang Xiaodong | Director | Nov 14, 2019 | Sale | $193.57 | 2,605 | 504,242 | 395 | Nov 18, 2019, 05:24 PM |
| Wang Xiaodong | Director | Nov 15, 2019 | Sale | $202.05 | 1,496 | 302,267 | 0 | Nov 18, 2019, 05:24 PM |
| Wang Xiaodong | Director | Nov 14, 2019 | Sale | $193.31 | 8,504 | 1,643,881 | 9,200 | Nov 18, 2019, 05:24 PM |
| Wu Xiaobin | President & GM China | Nov 15, 2019 | Sale | $202.05 | 1,000 | 202,050 | 0 | Nov 18, 2019, 05:22 PM |
| Huang Jane | CMO, Hematology | Nov 04, 2019 | Option Exercise | $29.49 | 32,900 | 970,221 | 32,900 | Nov 06, 2019, 06:51 PM |
| Huang Jane | CMO, Hematology | Nov 04, 2019 | Sale | $190.46 | 32,900 | 6,266,007 | 28,331 | Nov 06, 2019, 06:51 PM |
| Chen Timothy Yung-Cheng | Director | Nov 05, 2019 | Option Exercise | $41.01 | 4,000 | 164,040 | 4,000 | Nov 06, 2019, 06:50 PM |
| Chen Timothy Yung-Cheng | Director | Nov 04, 2019 | Option Exercise | $41.01 | 4,000 | 164,040 | 4,000 | Nov 06, 2019, 06:50 PM |
| Chen Timothy Yung-Cheng | Director | Nov 05, 2019 | Sale | $189.15 | 3,800 | 718,772 | 3,800 | Nov 06, 2019, 06:50 PM |
| Chen Timothy Yung-Cheng | Director | Nov 04, 2019 | Sale | $190.49 | 4,200 | 800,073 | 2,800 | Nov 06, 2019, 06:50 PM |
| Wang Xiaodong | Director | Nov 04, 2019 | Sale | $190.00 | 1,000 | 190,000 | 0 | Nov 05, 2019, 04:22 PM |
| Wang Xiaodong | Director | Nov 01, 2019 | Sale | $170.00 | 1,000 | 170,000 | 0 | Nov 05, 2019, 04:22 PM |
| Wu Xiaobin | President & GM China | Nov 01, 2019 | Sale | $180.00 | 1,000 | 180,000 | 0 | Nov 05, 2019, 04:20 PM |
| Huang Jane | CMO, Hematology | Sep 04, 2019 | Sale | $129.40 | 82 | 10,611 | 0 | Sep 05, 2019, 08:15 PM |
| Huang Jane | CMO, Hematology | Sep 03, 2019 | Sale | $144.45 | 2,862 | 413,419 | 230 | Sep 05, 2019, 08:15 PM |
| Chen Timothy Yung-Cheng | Director | Aug 23, 2019 | Option Exercise | $31.59 | 7,900 | 249,561 | 7,900 | Aug 27, 2019, 04:04 PM |
| Chen Timothy Yung-Cheng | Director | Aug 23, 2019 | Sale | $144.96 | 8,614 | 1,248,682 | 7,614 | Aug 27, 2019, 04:04 PM |
| Huang Jane | CMO, Hematology | Aug 12, 2019 | Option Exercise | $45.31 | 2,500 | 113,275 | 2,500 | Aug 13, 2019, 04:47 PM |
| Huang Jane | CMO, Hematology | Aug 12, 2019 | Sale | $134.74 | 2,500 | 336,855 | 1,700 | Aug 13, 2019, 04:47 PM |
| Huang Jane | CMO, Hematology | Jul 29, 2019 | Option Exercise | $37.30 | 10,130 | 377,834 | 10,130 | Jul 31, 2019, 04:04 PM |
| Huang Jane | CMO, Hematology | Jul 29, 2019 | Sale | $134.54 | 10,130 | 1,362,896 | 7,630 | Jul 31, 2019, 04:04 PM |
| OYLER JOHN | Chief Executive Officer | Jul 08, 2019 | Sale | $126.87 | 3,106 | 394,056 | 1,906 | Jul 09, 2019, 07:23 PM |
| Huang Jane | CMO, Hematology | Jun 27, 2019 | Sale | $124.52 | 430 | 53,542 | 3 | Jul 01, 2019, 08:30 PM |
| Liang Howard | CFO & Chief Strategy Officer | Jun 27, 2019 | Sale | $9.47 | 5,876 | 55,653 | 122,317 | Jul 01, 2019, 08:28 PM |
| Wang Xiaodong | Director | Jul 01, 2019 | Sale | $126.46 | 4,847 | 612,938 | 2,647 | Jul 01, 2019, 08:27 PM |
| Huang Jane | CMO, Hematology | May 21, 2019 | Option Exercise | $45.31 | 2,200 | 99,682 | 2,200 | May 22, 2019, 07:04 PM |
| Huang Jane | CMO, Hematology | May 20, 2019 | Option Exercise | $45.31 | 300 | 13,593 | 300 | May 22, 2019, 07:04 PM |
| Huang Jane | CMO, Hematology | May 21, 2019 | Sale | $130.06 | 2,200 | 286,132 | 0 | May 22, 2019, 07:04 PM |
| Huang Jane | CMO, Hematology | May 20, 2019 | Sale | $130.12 | 300 | 39,036 | 0 | May 22, 2019, 07:04 PM |
| Liang Howard | CFO & Chief Strategy Officer | May 21, 2019 | Option Exercise | $6.50 | 23,200 | 150,800 | 23,200 | May 22, 2019, 07:03 PM |
| Liang Howard | CFO & Chief Strategy Officer | May 21, 2019 | Sale | $130.21 | 23,200 | 3,020,872 | 0 | May 22, 2019, 07:03 PM |
| Glazer Donald W. | Director | May 13, 2019 | Sale | $125.11 | 15,027 | 1,880,028 | 0 | May 15, 2019, 03:59 PM |
| Liang Howard | CFO & Chief Strategy Officer | May 06, 2019 | Option Exercise | $6.50 | 1,800 | 11,700 | 1,800 | May 08, 2019, 05:53 PM |
| Liang Howard | CFO & Chief Strategy Officer | May 06, 2019 | Sale | $130.01 | 1,800 | 234,014 | 0 | May 08, 2019, 05:53 PM |
| Wu Xiaobin | President & GM China | May 01, 2019 | Sale | $124.53 | 5,955 | 741,547 | 23,135 | May 02, 2019, 04:08 PM |
| OYLER JOHN | Chief Executive Officer | May 01, 2019 | Sale | $125.18 | 2,824 | 353,504 | 1,422 | May 02, 2019, 04:07 PM |
| Huang Jane | CMO, Hematology | Apr 08, 2019 | Option Exercise | $29.49 | 14,130 | 416,694 | 14,130 | Apr 10, 2019, 06:41 PM |
| Huang Jane | CMO, Hematology | Apr 08, 2019 | Sale | $142.77 | 14,130 | 2,017,316 | 13,330 | Apr 10, 2019, 06:41 PM |
| Glazer Donald W. | Director | Mar 14, 2019 | Sale | $136.10 | 14,973 | 2,037,825 | 0 | Mar 18, 2019, 06:30 PM |
| Huang Jane | CMO, Hematology | Mar 11, 2019 | Option Exercise | $29.49 | 2,565 | 75,642 | 2,565 | Mar 11, 2019, 07:38 PM |
| Huang Jane | CMO, Hematology | Mar 11, 2019 | Sale | $130.00 | 2,565 | 333,450 | 0 | Mar 11, 2019, 07:38 PM |
| Huang Jane | CMO, Hematology | Mar 07, 2019 | Sale | $140.50 | 71 | 9,976 | 0 | Mar 11, 2019, 07:38 PM |
| OYLER JOHN | Chief Executive Officer | Mar 05, 2019 | Sale | $152.25 | 4,791 | 729,432 | 2,558 | Mar 06, 2019, 06:32 PM |
| OYLER JOHN | Chief Executive Officer | Mar 04, 2019 | Sale | $152.01 | 4,588 | 697,425 | 2,086 | Mar 06, 2019, 06:32 PM |
| OYLER JOHN | Chief Executive Officer | Mar 06, 2019 | Sale | $150.00 | 100 | 15,000 | 100 | Mar 06, 2019, 06:32 PM |
| OYLER JOHN | Chief Executive Officer | Mar 05, 2019 | Sale | $151.76 | 6,230 | 945,455 | 4,230 | Mar 06, 2019, 06:32 PM |
| OYLER JOHN | Chief Executive Officer | Mar 04, 2019 | Sale | $151.34 | 9,790 | 1,481,625 | 3,700 | Mar 06, 2019, 06:32 PM |
| Wang Xiaodong | Director | Mar 01, 2019 | Sale | $150.00 | 1,000 | 150,000 | 0 | Mar 05, 2019, 12:00 AM |
| Wang Xiaodong | Director | Mar 01, 2019 | Sale | $146.03 | 4,000 | 584,125 | 2,700 | Mar 05, 2019, 12:00 AM |
| Peterson Amy C. | CMO, Immuno-oncology | Dec 17, 2018 | Option Exercise | $29.10 | 9,859 | 286,897 | 9,859 | Dec 19, 2018, 06:34 PM |
| Peterson Amy C. | CMO, Immuno-oncology | Dec 18, 2018 | Option Exercise | $29.10 | 10,141 | 295,103 | 10,141 | Dec 19, 2018, 06:34 PM |
| Peterson Amy C. | CMO, Immuno-oncology | Dec 17, 2018 | Sale | $133.61 | 9,859 | 1,317,225 | 8,959 | Dec 19, 2018, 06:34 PM |
| Peterson Amy C. | CMO, Immuno-oncology | Dec 18, 2018 | Sale | $133.75 | 10,141 | 1,356,312 | 8,510 | Dec 19, 2018, 06:34 PM |
| OYLER JOHN | Chief Executive Officer | Dec 10, 2018 | Sale | $135.78 | 4,138 | 561,863 | 3,738 | Dec 12, 2018, 05:28 PM |
| Wang Xiaodong | Director | Dec 03, 2018 | Sale | $152.41 | 5,000 | 762,060 | 2,329 | Dec 04, 2018, 05:35 PM |
| OYLER JOHN | Chief Executive Officer | Nov 26, 2018 | Sale | $139.06 | 9,078 | 1,262,428 | 33,133 | Nov 28, 2018, 07:26 PM |
| OYLER JOHN | Chief Executive Officer | Nov 28, 2018 | Sale | $147.19 | 8,865 | 1,304,863 | 12,503 | Nov 28, 2018, 07:26 PM |
| OYLER JOHN | Chief Executive Officer | Nov 27, 2018 | Sale | $144.57 | 11,252 | 1,626,741 | 24,055 | Nov 28, 2018, 07:26 PM |
| Huang Jane | CMO, Hematology | Nov 26, 2018 | Option Exercise | $29.49 | 3,000 | 88,470 | 3,000 | Nov 28, 2018, 07:25 PM |
| Huang Jane | CMO, Hematology | Nov 26, 2018 | Sale | $139.58 | 3,000 | 418,749 | 0 | Nov 28, 2018, 07:25 PM |
| Wang Xiaodong | Director | Nov 19, 2018 | Sale | $124.30 | 5,000 | 621,489 | 3,900 | Nov 21, 2018, 06:41 PM |
| Peterson Amy C. | CMO, Immuno-oncology | Nov 09, 2018 | Option Exercise | $29.10 | 13,222 | 384,760 | 13,222 | Nov 13, 2018, 10:20 AM |
| Peterson Amy C. | CMO, Immuno-oncology | Nov 08, 2018 | Option Exercise | $29.10 | 14,711 | 428,090 | 14,711 | Nov 13, 2018, 10:20 AM |
| Peterson Amy C. | CMO, Immuno-oncology | Nov 12, 2018 | Option Exercise | $29.10 | 12,067 | 351,150 | 12,067 | Nov 13, 2018, 10:20 AM |
| Peterson Amy C. | CMO, Immuno-oncology | Nov 08, 2018 | Sale | $126.07 | 14,711 | 1,854,578 | 14,245 | Nov 13, 2018, 10:20 AM |
| Peterson Amy C. | CMO, Immuno-oncology | Nov 12, 2018 | Sale | $112.73 | 12,067 | 1,360,348 | 9,109 | Nov 13, 2018, 10:20 AM |
| Peterson Amy C. | CMO, Immuno-oncology | Nov 09, 2018 | Sale | $120.49 | 13,222 | 1,593,163 | 9,191 | Nov 13, 2018, 10:20 AM |
| Huang Jane | CMO, Hematology | Sep 04, 2018 | Sale | $174.60 | 2,911 | 508,246 | 0 | Sep 05, 2018, 05:15 PM |
| Glazer Donald W. | Director | Aug 30, 2018 | Sale | $179.00 | 1,000 | 179,000 | 13,384 | Aug 31, 2018, 04:54 PM |
| Glazer Donald W. | Director | Aug 29, 2018 | Sale | $179.00 | 1,000 | 179,000 | 14,384 | Aug 31, 2018, 04:54 PM |
| Peterson Amy C. | CMO, Immuno-oncology | Aug 23, 2018 | Sale | $169.12 | 5,769 | 975,665 | 4,661 | Aug 24, 2018, 04:25 PM |
| Wang Xiaodong | Director | Aug 13, 2018 | Sale | $158.77 | 3,449 | 547,591 | 1,249 | Aug 15, 2018, 04:23 PM |
| BAKER BROS. ADVISORS LP | Director | Aug 02, 2018 | Buy | $108.00 | 5,814,100 | 627,922,800 | 5,250,491 | Aug 06, 2018, 05:22 PM |
| OYLER JOHN | Chief Executive Officer | Jul 16, 2018 | Sale | $164.12 | 2,550 | 418,498 | 0 | Jul 17, 2018, 05:02 PM |
| Liang Howard | CFO & Chief Strategy Officer | Mar 16, 2018 | Option Exercise | $6.50 | 10,872 | 70,668 | 15,872 | Mar 20, 2018, 05:02 PM |
| Liang Howard | CFO & Chief Strategy Officer | Mar 19, 2018 | Option Exercise | $6.50 | 24,128 | 156,832 | 29,128 | Mar 20, 2018, 05:02 PM |
| Liang Howard | CFO & Chief Strategy Officer | Mar 19, 2018 | Sale | $161.46 | 29,128 | 4,702,982 | 28,628 | Mar 20, 2018, 05:02 PM |
| Liang Howard | CFO & Chief Strategy Officer | Mar 16, 2018 | Sale | $157.07 | 10,872 | 1,707,669 | 14,872 | Mar 20, 2018, 05:02 PM |
| OYLER JOHN | Chief Executive Officer | Mar 02, 2018 | Sale | $148.13 | 25,362 | 3,756,785 | 24,062 | Mar 02, 2018, 06:42 PM |
| OYLER JOHN | Chief Executive Officer | Mar 01, 2018 | Sale | $143.08 | 39,300 | 5,623,203 | 62,062 | Mar 02, 2018, 06:42 PM |
| OYLER JOHN | Chief Executive Officer | Feb 28, 2018 | Sale | $146.69 | 34,338 | 5,036,940 | 93,883 | Mar 02, 2018, 06:42 PM |
| Li Ji | EVP and Gl. Head of Bus. Dev. | Feb 28, 2018 | Option Exercise | $26.65 | 10,000 | 266,500 | 10,000 | Mar 02, 2018, 06:41 PM |
| Li Ji | EVP and Gl. Head of Bus. Dev. | Feb 28, 2018 | Sale | $146.88 | 10,000 | 1,468,761 | 8,251 | Mar 02, 2018, 06:41 PM |
| BAKER BROS. ADVISORS LP | Director | Jan 18, 2018 | Buy | $101.00 | 1,980,198 | 199,999,998 | 5,121,404 | Jan 22, 2018, 05:03 PM |
| OYLER JOHN | Chief Executive Officer | Dec 26, 2017 | Sale | $96.46 | 20,137 | 1,942,515 | 110,179 | Dec 28, 2017, 05:49 PM |
| Huang Jane | CMO, Hematology | Dec 21, 2017 | Option Exercise | $29.51 | 1,000 | 29,510 | 1,000 | Dec 22, 2017, 04:43 PM |
| Huang Jane | CMO, Hematology | Dec 21, 2017 | Sale | $98.00 | 1,000 | 98,000 | 0 | Dec 22, 2017, 04:43 PM |
| Huang Jane | CMO, Hematology | Dec 13, 2017 | Option Exercise | $29.51 | 1,500 | 44,265 | 1,500 | Dec 15, 2017, 04:05 PM |
| Huang Jane | CMO, Hematology | Dec 13, 2017 | Sale | $94.25 | 1,500 | 141,381 | 200 | Dec 15, 2017, 04:05 PM |
| OYLER JOHN | Chief Executive Officer | Dec 07, 2017 | Sale | $93.40 | 59,737 | 5,579,304 | 207,611 | Dec 08, 2017, 05:57 PM |
| OYLER JOHN | Chief Executive Officer | Dec 06, 2017 | Sale | $92.29 | 31,446 | 2,902,224 | 255,137 | Dec 08, 2017, 05:57 PM |
| OYLER JOHN | Chief Executive Officer | Dec 08, 2017 | Sale | $95.57 | 52,817 | 5,047,758 | 161,145 | Dec 08, 2017, 05:57 PM |
| Huang Jane | CMO, Hematology | Dec 04, 2017 | Sale | $86.00 | 1,100 | 94,600 | 0 | Dec 05, 2017, 09:15 AM |
| OYLER JOHN | Chief Executive Officer | Nov 29, 2017 | Sale | $82.92 | 36,340 | 3,013,458 | 263,137 | Nov 29, 2017, 05:33 PM |
| OYLER JOHN | Chief Executive Officer | Nov 28, 2017 | Sale | $85.52 | 32,985 | 2,820,864 | 299,477 | Nov 29, 2017, 05:33 PM |
| OYLER JOHN | Chief Executive Officer | Nov 27, 2017 | Sale | $86.76 | 16,581 | 1,438,582 | 332,697 | Nov 29, 2017, 05:33 PM |
| Huang Jane | CMO, Hematology | Nov 16, 2017 | Sale | $85.00 | 600 | 51,000 | 2,100 | Nov 20, 2017, 05:14 PM |
| Huang Jane | CMO, Hematology | Nov 20, 2017 | Sale | $87.00 | 1,000 | 87,000 | 1,100 | Nov 20, 2017, 05:14 PM |
| OYLER JOHN | Chief Executive Officer | Nov 15, 2017 | Sale | $80.23 | 66,068 | 5,300,508 | 411,313 | Nov 15, 2017, 08:12 PM |
| OYLER JOHN | Chief Executive Officer | Nov 14, 2017 | Sale | $79.74 | 59,835 | 4,770,950 | 435,618 | Nov 15, 2017, 08:12 PM |
| OYLER JOHN | Chief Executive Officer | Nov 13, 2017 | Sale | $83.06 | 25,054 | 2,080,916 | 491,891 | Nov 15, 2017, 08:12 PM |
| Peterson Amy C. | CMO, Immuno-oncology | Nov 13, 2017 | Sale | $82.96 | 3,601 | 298,747 | 1,201 | Nov 15, 2017, 08:11 PM |
| Peterson Amy C. | CMO, Immuno-oncology | Aug 22, 2017 | Option Exercise | $5.39 | 28,185 | 151,830 | 271,815 | Aug 24, 2017, 04:20 PM |
| BAKER BROS. ADVISORS LP | Director | Aug 11, 2017 | Buy | $71.00 | 176,056 | 12,499,976 | 3,476,256 | Aug 14, 2017, 03:49 PM |
| Wang Xiaodong | Director | Jul 12, 2017 | Sale | $72.44 | 20,000 | 1,448,704 | 16,300 | Jul 13, 2017, 06:31 PM |
| Glazer Donald W. | Director | Jul 10, 2017 | Sale | $72.15 | 10,810 | 779,900 | 7,206 | Jul 12, 2017, 09:37 PM |
| OYLER JOHN | Chief Executive Officer | Jul 06, 2017 | Sale | $64.82 | 219,400 | 14,221,125 | 212,055 | Jul 10, 2017, 06:44 PM |
| Wang Xiaodong | Director | Jun 28, 2017 | Sale | $44.95 | 35,000 | 1,573,345 | 26,600 | Jun 30, 2017, 04:36 PM |
| OYLER JOHN | Chief Executive Officer | Jun 22, 2017 | Sale | $44.08 | 58,605 | 2,583,269 | 88,535 | Jun 26, 2017, 08:38 PM |
| OYLER JOHN | Chief Executive Officer | Jun 23, 2017 | Sale | $44.28 | 39,895 | 1,766,353 | 62,321 | Jun 26, 2017, 08:38 PM |
| Wang Xiaodong | Director | Jun 02, 2017 | Sale | $40.00 | 5,539 | 221,560 | 55,000 | Jun 06, 2017, 04:20 PM |
| Wang Xiaodong | Director | May 04, 2017 | Sale | $41.01 | 4,491 | 184,171 | 60,539 | May 05, 2017, 05:50 PM |
| Wang Xiaodong | Director | May 03, 2017 | Sale | $40.71 | 9,970 | 405,871 | 65,030 | May 05, 2017, 05:50 PM |
| OYLER JOHN | Chief Executive Officer | May 01, 2017 | Sale | $42.02 | 2,100 | 88,243 | 145,340 | May 01, 2017, 07:44 PM |
| OYLER JOHN | Chief Executive Officer | Apr 27, 2017 | Sale | $40.37 | 34,049 | 1,374,565 | 147,440 | May 01, 2017, 07:44 PM |
| Wang Xiaodong | Director | Apr 05, 2017 | Sale | $36.83 | 11,650 | 429,085 | 81,194 | Apr 07, 2017, 05:10 PM |
| Wang Xiaodong | Director | Mar 24, 2017 | Sale | $36.60 | 18,787 | 687,634 | 86,850 | Mar 24, 2017, 06:57 PM |
| Wang Xiaodong | Director | Mar 23, 2017 | Sale | $36.99 | 11,041 | 408,462 | 105,437 | Mar 24, 2017, 06:57 PM |
| Wang Xiaodong | Director | Mar 22, 2017 | Sale | $37.75 | 8,279 | 312,517 | 116,478 | Mar 24, 2017, 06:57 PM |
| OYLER JOHN | Chief Executive Officer | Mar 20, 2017 | Sale | $40.02 | 13,234 | 529,611 | 181,489 | Mar 20, 2017, 07:06 PM |
| OYLER JOHN | Chief Executive Officer | Mar 17, 2017 | Sale | $40.02 | 2,717 | 108,737 | 194,723 | Mar 20, 2017, 07:06 PM |
| OYLER JOHN | Chief Executive Officer | Mar 16, 2017 | Sale | $38.77 | 16,038 | 621,725 | 197,640 | Mar 20, 2017, 07:06 PM |
| Wang Xiaodong | Director | Mar 10, 2017 | Sale | $39.94 | 7,304 | 291,702 | 124,757 | Mar 10, 2017, 07:16 PM |
| Wang Xiaodong | Director | Mar 09, 2017 | Sale | $39.95 | 18,596 | 742,843 | 132,061 | Mar 10, 2017, 07:16 PM |
| Wang Xiaodong | Director | Mar 08, 2017 | Sale | $39.78 | 10,992 | 437,211 | 150,657 | Mar 10, 2017, 07:16 PM |
| OYLER JOHN | Chief Executive Officer | Mar 06, 2017 | Sale | $40.23 | 19,816 | 797,258 | 217,708 | Mar 06, 2017, 07:00 PM |
| OYLER JOHN | Chief Executive Officer | Mar 03, 2017 | Sale | $40.83 | 40,091 | 1,636,968 | 241,794 | Mar 06, 2017, 07:00 PM |
| OYLER JOHN | Chief Executive Officer | Mar 02, 2017 | Sale | $41.25 | 49,092 | 2,025,104 | 273,385 | Mar 06, 2017, 07:00 PM |
| Wang Xiaodong | Director | Feb 24, 2017 | Sale | $38.14 | 28,402 | 1,083,114 | 166,593 | Feb 27, 2017, 09:11 PM |
| Wang Xiaodong | Director | Feb 23, 2017 | Sale | $38.57 | 5,505 | 212,351 | 194,495 | Feb 27, 2017, 09:11 PM |
| Wang Xiaodong | Director | Feb 27, 2017 | Sale | $38.10 | 4,444 | 169,328 | 161,649 | Feb 27, 2017, 09:11 PM |
| OYLER JOHN | Chief Executive Officer | Feb 21, 2017 | Sale | $39.98 | 10,359 | 414,162 | 325,410 | Feb 21, 2017, 07:23 PM |
| OYLER JOHN | Chief Executive Officer | Feb 17, 2017 | Sale | $40.67 | 7,204 | 292,981 | 332,836 | Feb 21, 2017, 07:23 PM |
| OYLER JOHN | Chief Executive Officer | Feb 16, 2017 | Sale | $40.65 | 47,400 | 1,926,867 | 378,383 | Feb 21, 2017, 07:23 PM |
| Wang Xiaodong | Director | Nov 23, 2016 | Sale | $32.00 | 93,750 | 3,000,000 | 0 | Nov 28, 2016, 04:04 PM |
| Malley Thomas | Director | Nov 23, 2016 | Buy | $32.00 | 30,000 | 960,000 | 30,000 | Nov 28, 2016, 04:02 PM |
| BAKER BROS. ADVISORS LP | Director | Nov 18, 2016 | Buy | $32.00 | 1,760,495 | 56,335,840 | 3,317,977 | Nov 21, 2016, 06:13 PM |
| Glazer Donald W. | Director | Sep 28, 2016 | Sale | $30.66 | 41,463 | 1,271,175 | 11,300 | Sep 30, 2016, 04:50 PM |
| Glazer Donald W. | Director | Sep 27, 2016 | Sale | $29.63 | 26,483 | 784,691 | 41,463 | Sep 28, 2016, 04:11 PM |
| Glazer Donald W. | Director | Sep 26, 2016 | Sale | $29.58 | 20,666 | 611,300 | 67,946 | Sep 28, 2016, 04:11 PM |
| Glazer Donald W. | Director | Sep 22, 2016 | Sale | $31.13 | 25,010 | 778,561 | 100,045 | Sep 26, 2016, 06:12 PM |
| Glazer Donald W. | Director | Sep 23, 2016 | Sale | $30.77 | 11,433 | 351,793 | 88,612 | Sep 26, 2016, 06:12 PM |
| Glazer Donald W. | Director | Sep 21, 2016 | Sale | $31.19 | 16,318 | 508,958 | 125,055 | Sep 21, 2016, 09:11 PM |
| Glazer Donald W. | Director | Sep 20, 2016 | Sale | $31.01 | 8,243 | 255,615 | 141,373 | Sep 21, 2016, 09:11 PM |
| Glazer Donald W. | Director | Sep 19, 2016 | Sale | $31.59 | 42,691 | 1,348,487 | 151,516 | Sep 21, 2016, 09:11 PM |
| Liang Howard | CFO & Chief Strategy Officer | Feb 08, 2016 | Buy | $1.85 | 65,000 | 120,250 | 65,000 | Feb 09, 2016, 08:08 PM |
| Yuan RuiRong | Chief Medical Officer | Feb 08, 2016 | Buy | $1.85 | 130,000 | 240,500 | 130,000 | Feb 09, 2016, 08:08 PM |
| BAKER BROS. ADVISORS LP | Director | Feb 08, 2016 | Buy | $24.00 | 1,912,680 | 45,904,320 | 1,723,306 | Feb 09, 2016, 05:38 PM |
| BAKER BROS. ADVISORS LP | Director | Feb 08, 2016 | Option Exercise | $0.68 | 2,592,593 | 1,750,000 | 73,162,022 | Feb 09, 2016, 05:38 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
| Owner | Relationship | Date | Value($) |
| OYLER JOHN | Chief Executive Officer | 04/11/2024 | 1,773,085 |
| OYLER JOHN | Chief Executive Officer | 04/10/2024 | 3,977,861 |
| OYLER JOHN | Chief Executive Officer | 04/09/2024 | 1,724,078 |
| OYLER JOHN | Chief Executive Officer | 03/13/2024 | 2,189,648 |
| OYLER JOHN | Chief Executive Officer | 03/12/2024 | 6,178,369 |
| Wang Julia Aijun | Chief Financial Officer | 02/29/2024 | 66,331 |
| BAKER BROS. ADVISORS LP | Director | 11/14/2023 | 198,550,000 |
| Lee Chan Henry | SVP, General Counsel | 07/31/2023 | 171,059 |
| Wang Julia Aijun | Chief Financial Officer | 07/03/2023 | 84,747 |
| Wang Lai | Global Head of R&D | 06/26/2023 | 201,567 |
| Wang Julia Aijun | Chief Financial Officer | 06/23/2023 | 153,594 |
| Sanders Corazon (Corsee) D. | Director | 06/23/2023 | 105,381 |
| Wu Xiaobin | President, COO & GM China | 06/26/2023 | 272,636 |
| Wang Lai | Global Head of R&D | 06/20/2023 | 254,955 |
| HHLR ADVISORS, LTD. | 10% Owner | 06/14/2023 | 56,857,987 |
| HHLR ADVISORS, LTD. | 10% Owner | 06/13/2023 | 169,448,350 |
| HHLR ADVISORS, LTD. | 10% Owner | 06/08/2023 | 253,881,793 |
| HHLR ADVISORS, LTD. | 10% Owner | 06/12/2023 | 244,057,184 |
| HHLR ADVISORS, LTD. | 10% Owner | 06/09/2023 | 99,244,888 |
| Wang Lai | Global Head of R&D | 06/07/2023 | 103,828 |
| Wu Xiaobin | President, COO & GM China | 06/07/2023 | 739,599 |
| Wu Xiaobin | President, COO & GM China | 05/08/2023 | 1,776,037 |
| Wang Xiaodong | Director | 03/08/2023 | 8,793 |
| Wang Xiaodong | Director | 03/08/2023 | 15,287,339 |
| Wang Xiaodong | Director | 01/12/2023 | 1,302,585 |
| OYLER JOHN | Chief Executive Officer | 01/10/2023 | 3,378,292 |
| OYLER JOHN | Chief Executive Officer | 01/10/2023 | 1,689,157 |
| Wang Xiaodong | Director | 01/11/2023 | 631,647 |
| Wang Xiaodong | Director | 01/10/2023 | 400,152 |
| Wang Xiaodong | Director | 01/09/2023 | 225,000 |
| OYLER JOHN | Chief Executive Officer | 12/29/2022 | 385,174 |
| OYLER JOHN | Chief Executive Officer | 12/28/2022 | 164,724 |
| OYLER JOHN | Chief Executive Officer | 12/28/2022 | 82,474 |
| OYLER JOHN | Chief Executive Officer | 12/27/2022 | 502,193 |
| OYLER JOHN | Chief Executive Officer | 12/27/2022 | 251,209 |
| OYLER JOHN | Chief Executive Officer | 12/29/2022 | 770,798 |
| Wang Xiaodong | Director | 12/13/2022 | 636,724 |
| Wang Xiaodong | Director | 11/15/2022 | 417,542 |
| OYLER JOHN | Chief Executive Officer | 11/15/2022 | 1,019,229 |
| OYLER JOHN | Chief Executive Officer | 11/15/2022 | 5,171,104 |
| OYLER JOHN | Chief Executive Officer | 09/21/2022 | 2,921,712 |
| OYLER JOHN | Chief Executive Officer | 09/20/2022 | 4,684,837 |
| Wang Xiaodong | Director | 08/05/2022 | 969,272 |
| Wang Xiaodong | Director | 08/08/2022 | 1,219,594 |
| Wang Xiaodong | Director | 08/05/2022 | 969,256 |
| Wang Julia Aijun | Chief Financial Officer | 07/01/2022 | 50,245 |
| Wang Julia Aijun | Chief Financial Officer | 07/01/2022 | 46,758 |
| Wang Lai | Global Head of R&D | 06/27/2022 | 81,215 |
| Wang Lai | Global Head of R&D | 06/21/2022 | 107,734 |
| Wang Lai | Global Head of R&D | 06/17/2022 | 62,034 |
| Wu Xiaobin | President, COO & GM China | 06/21/2022 | 145,804 |
| Wu Xiaobin | President, COO & GM China | 06/17/2022 | 80,691 |
| Wang Julia Aijun | Chief Financial Officer | 06/17/2022 | 21,999 |
| Wang Lai | Global Head of R&D | 06/06/2022 | 93,717 |
| Wu Xiaobin | President, COO & GM China | 06/06/2022 | 484,203 |
| Wang Lai | Global Head of R&D | 05/17/2022 | 4,025,737 |
| Wu Xiaobin | President, COO & GM China | 05/05/2022 | 1,105,275 |
| Huang Jane | CMO, Hematology | 12/14/2021 | 179,940 |
| Huang Jane | CMO, Hematology | 12/14/2021 | 417,211 |
| Huang Jane | CMO, Hematology | 12/01/2021 | 377,493 |
| Huang Jane | CMO, Hematology | 11/17/2021 | 179,940 |
| Huang Jane | CMO, Hematology | 11/17/2021 | 572,003 |
| Wang Xiaodong | Director | 11/08/2021 | 1,575,202 |
| Wang Xiaodong | Director | 11/08/2021 | 1,574,148 |
| Wu Xiaobin | President, COO & GM China | 11/09/2021 | 855,038 |
| Wu Xiaobin | President, COO & GM China | 11/08/2021 | 2,727,625 |
| Huang Jane | CMO, Hematology | 10/19/2021 | 179,940 |
| Huang Jane | CMO, Hematology | 10/19/2021 | 559,163 |
| Huang Jane | CMO, Hematology | 09/20/2021 | 719,760 |
| Huang Jane | CMO, Hematology | 09/20/2021 | 2,387,774 |
| OYLER JOHN | Chief Executive Officer | 09/15/2021 | 15,439,460 |
| OYLER JOHN | Chief Executive Officer | 09/14/2021 | 18,348,858 |
| Huang Jane | CMO, Hematology | 09/13/2021 | 4,620,392 |
| AMGEN INC | 10% Owner | 09/10/2021 | 49,999,856 |
| OYLER JOHN | Chief Executive Officer | 09/02/2021 | 8,040,809 |
| OYLER JOHN | Chief Executive Officer | 09/01/2021 | 11,411,639 |
| OYLER JOHN | Chief Executive Officer | 08/31/2021 | 12,232,867 |
| Huang Jane | CMO, Hematology | 09/02/2021 | 178,314 |
| Huang Jane | CMO, Hematology | 09/01/2021 | 168,307 |
| OYLER JOHN | Chief Executive Officer | 08/05/2021 | 4,378,046 |
| OYLER JOHN | Chief Executive Officer | 08/04/2021 | 12,205,592 |
| OYLER JOHN | Chief Executive Officer | 08/03/2021 | 15,202,040 |
| OYLER JOHN | Chief Executive Officer | 07/22/2021 | 4,971,359 |
| OYLER JOHN | Chief Executive Officer | 07/21/2021 | 4,999,824 |
| OYLER JOHN | Chief Executive Officer | 07/20/2021 | 5,779,054 |
| Huang Jane | CMO, Hematology | 07/15/2021 | 3,085,002 |
| Huang Jane | CMO, Hematology | 07/15/2021 | 6,980,771 |
| OYLER JOHN | Chief Executive Officer | 07/07/2021 | 97,570 |
| OYLER JOHN | Chief Executive Officer | 07/08/2021 | 6,301,730 |
| OYLER JOHN | Chief Executive Officer | 07/07/2021 | 9,139,023 |
| OYLER JOHN | Chief Executive Officer | 07/06/2021 | 5,375,612 |
| Wu Xiaobin | President, COO & GM China | 07/06/2021 | 3,313,928 |
| Wang Xiaodong | Director | 07/01/2021 | 1,687,852 |
| Wang Julia Aijun | Chief Financial Officer | 07/01/2021 | 107,512 |
| Huang Jane | CMO, Hematology | 06/29/2021 | 44,235 |
| Huang Jane | CMO, Hematology | 06/29/2021 | 528,198 |
| Huang Jane | CMO, Hematology | 06/28/2021 | 155,125 |
| Wang Lai | Global Head of R&D | 06/28/2021 | 164,930 |
| Liang Howard | CFO & Chief Strategy Officer | 06/28/2021 | 162,790 |
| Huang Jane | CMO, Hematology | 06/18/2021 | 152,733 |
| Chen Timothy Yung-Cheng | Director | 06/09/2021 | 99,951 |
| Chen Timothy Yung-Cheng | Director | 06/10/2021 | 89,589 |
| Chen Timothy Yung-Cheng | Director | 06/09/2021 | 1,111,669 |
| Chen Timothy Yung-Cheng | Director | 06/10/2021 | 998,348 |
| Wu Xiaobin | President, COO & GM China | 06/07/2021 | 1,197,918 |
| Huang Jane | CMO, Hematology | 06/07/2021 | 211,986 |
| Wang Xiaodong | Director | 05/10/2021 | 6,175 |
| Wang Xiaodong | Director | 05/10/2021 | 1,019,751 |
| Huang Jane | CMO, Hematology | 04/29/2021 | 44,235 |
| Huang Jane | CMO, Hematology | 04/29/2021 | 532,387 |
| Huang Jane | CMO, Hematology | 03/29/2021 | 44,235 |
| Huang Jane | CMO, Hematology | 03/29/2021 | 485,993 |
| Huang Jane | CMO, Hematology | 02/26/2021 | 44,235 |
| Huang Jane | CMO, Hematology | 02/26/2021 | 481,099 |
| Huang Jane | CMO, Hematology | 01/29/2021 | 44,235 |
| Huang Jane | CMO, Hematology | 01/29/2021 | 484,492 |
| Liang Howard | CFO & Chief Strategy Officer | 01/15/2021 | 81,900 |
| Liang Howard | CFO & Chief Strategy Officer | 01/14/2021 | 9,100 |
| Liang Howard | CFO & Chief Strategy Officer | 01/15/2021 | 4,345,687 |
| Liang Howard | CFO & Chief Strategy Officer | 01/14/2021 | 482,256 |
| BAKER BROS. ADVISORS LP | Director | 01/04/2021 | 26,714,457 |
| Huang Jane | CMO, Hematology | 12/29/2020 | 44,235 |
| Huang Jane | CMO, Hematology | 12/29/2020 | 373,690 |
| AMGEN INC | 10% Owner | 12/18/2020 | 6,722,516 |
| AMGEN INC | 10% Owner | 12/17/2020 | 19,442,538 |
| AMGEN INC | 10% Owner | 12/16/2020 | 21,244,439 |
| AMGEN INC | 10% Owner | 12/15/2020 | 16,258,757 |
| Liang Howard | CFO & Chief Strategy Officer | 12/14/2020 | 1,300,000 |
| Liang Howard | CFO & Chief Strategy Officer | 12/14/2020 | 21,048,471 |
| BAKER BROS. ADVISORS LP | Director | 12/04/2020 | 333,295,893 |
| Huang Jane | CMO, Hematology | 11/30/2020 | 44,235 |
| Huang Jane | CMO, Hematology | 11/30/2020 | 401,722 |
| Huang Jane | CMO, Hematology | 10/29/2020 | 44,235 |
| Huang Jane | CMO, Hematology | 10/29/2020 | 450,092 |
| Wang Xiaodong | Director | 10/16/2020 | 1,600,000 |
| Wang Xiaodong | Director | 10/05/2020 | 1,500,000 |
| Wu Xiaobin | President & GM China | 10/05/2020 | 1,200,000 |
| Liang Howard | CFO & Chief Strategy Officer | 10/05/2020 | 91,000 |
| Liang Howard | CFO & Chief Strategy Officer | 10/05/2020 | 4,194,415 |
| Huang Jane | CMO, Hematology | 09/29/2020 | 44,235 |
| Huang Jane | CMO, Hematology | 09/29/2020 | 420,568 |
| OYLER JOHN | Chief Executive Officer | 09/29/2020 | 6,544,031 |
| OYLER JOHN | Chief Executive Officer | 09/28/2020 | 8,682,061 |
| Wang Xiaodong | Director | 09/25/2020 | 1,402,117 |
| Wu Xiaobin | President & GM China | 09/25/2020 | 1,121,408 |
| Wang Xiaodong | Director | 09/17/2020 | 1,301,358 |
| Wu Xiaobin | President & GM China | 09/17/2020 | 1,041,326 |
| OYLER JOHN | Chief Executive Officer | 09/15/2020 | 8,699,382 |
| OYLER JOHN | Chief Executive Officer | 09/14/2020 | 4,939,776 |
| OYLER JOHN | Chief Executive Officer | 09/16/2020 | 6,948,803 |
| Liang Howard | CFO & Chief Strategy Officer | 09/14/2020 | 91,000 |
| Liang Howard | CFO & Chief Strategy Officer | 09/14/2020 | 3,503,765 |
| Huang Jane | CMO, Hematology | 09/03/2020 | 729,044 |
| OYLER JOHN | Chief Executive Officer | 09/01/2020 | 4,739,812 |
| OYLER JOHN | Chief Executive Officer | 08/31/2020 | 3,121,766 |
| OYLER JOHN | Chief Executive Officer | 09/02/2020 | 6,374,025 |
| Huang Jane | CMO, Hematology | 08/28/2020 | 88,470 |
| Huang Jane | CMO, Hematology | 08/28/2020 | 726,627 |
| AMGEN INC | 10% Owner | 08/25/2020 | 14,757,583 |
| AMGEN INC | 10% Owner | 08/21/2020 | 14,772,031 |
| AMGEN INC | 10% Owner | 08/24/2020 | 14,199,911 |
| OYLER JOHN | Chief Executive Officer | 08/21/2020 | 9,796,779 |
| OYLER JOHN | Chief Executive Officer | 08/20/2020 | 5,049,747 |
| OYLER JOHN | Chief Executive Officer | 08/19/2020 | 7,005,270 |
| AMGEN INC | 10% Owner | 08/20/2020 | 15,080,975 |
| AMGEN INC | 10% Owner | 08/19/2020 | 15,073,466 |
| AMGEN INC | 10% Owner | 08/18/2020 | 9,207,200 |
| OYLER JOHN | Chief Executive Officer | 08/14/2020 | 1,838,037 |
| OYLER JOHN | Chief Executive Officer | 08/13/2020 | 3,097,763 |
| OYLER JOHN | Chief Executive Officer | 08/12/2020 | 4,203,769 |
| Chen Timothy Yung-Cheng | Director | 08/11/2020 | 60,116 |
| Chen Timothy Yung-Cheng | Director | 08/10/2020 | 69,498 |
| Chen Timothy Yung-Cheng | Director | 08/12/2020 | 91,516 |
| Chen Timothy Yung-Cheng | Director | 08/10/2020 | 470,886 |
| Chen Timothy Yung-Cheng | Director | 08/12/2020 | 614,164 |
| Chen Timothy Yung-Cheng | Director | 08/11/2020 | 405,409 |
| Wang Xiaodong | Director | 08/10/2020 | 844,229 |
| OYLER JOHN | Chief Executive Officer | 08/05/2020 | 3,852,275 |
| OYLER JOHN | Chief Executive Officer | 08/04/2020 | 3,390,953 |
| OYLER JOHN | Chief Executive Officer | 08/03/2020 | 5,583,571 |
| Huang Jane | CMO, Hematology | 07/29/2020 | 284,835 |
| Huang Jane | CMO, Hematology | 07/29/2020 | 629,787 |
| OYLER JOHN | Chief Executive Officer | 07/22/2020 | 6,613,501 |
| OYLER JOHN | Chief Executive Officer | 07/21/2020 | 6,651,693 |
| OYLER JOHN | Chief Executive Officer | 07/20/2020 | 7,243,786 |
| Wang Xiaodong | Director | 07/20/2020 | 1,259,896 |
| Wang Xiaodong | Director | 07/20/2020 | 3,015,742 |
| Wu Xiaobin | President & GM China | 07/20/2020 | 650,408 |
| Wu Xiaobin | President & GM China | 07/17/2020 | 172,015 |
| BAKER BROS. ADVISORS LP | Director | 07/15/2020 | 207,544,544 |
| AMGEN INC | 10% Owner | 07/15/2020 | 421,442,742 |
| Wu Xiaobin | President & GM China | 07/13/2020 | 660,000 |
| Wu Xiaobin | President & GM China | 07/15/2020 | 650,998 |
| Wang Xiaodong | Director | 07/07/2020 | 1,200,000 |
| Huang Jane | CMO, Hematology | 07/07/2020 | 628,928 |
| Huang Jane | CMO, Hematology | 07/07/2020 | 784,200 |
| OYLER JOHN | Chief Executive Officer | 07/08/2020 | 3,530,204 |
| OYLER JOHN | Chief Executive Officer | 07/07/2020 | 3,782,991 |
| OYLER JOHN | Chief Executive Officer | 07/06/2020 | 3,422,258 |
| Wang Xiaodong | Director | 07/01/2020 | 924,572 |
| OYLER JOHN | Chief Executive Officer | 07/01/2020 | 731,017 |
| OYLER JOHN | Chief Executive Officer | 06/29/2020 | 276,374 |
| Liang Howard | CFO & Chief Strategy Officer | 06/29/2020 | 57,368 |
| Huang Jane | CMO, Hematology | 06/26/2020 | 333,472 |
| Huang Jane | CMO, Hematology | 06/29/2020 | 44,235 |
| Huang Jane | CMO, Hematology | 06/29/2020 | 369,250 |
| Huang Jane | CMO, Hematology | 06/26/2020 | 416,396 |
| OYLER JOHN | Chief Executive Officer | 06/24/2020 | 2,694,154 |
| OYLER JOHN | Chief Executive Officer | 06/23/2020 | 2,816,221 |
| OYLER JOHN | Chief Executive Officer | 06/22/2020 | 1,875,605 |
| Wang Xiaodong | Director | 06/23/2020 | 1,118,297 |
| Wang Xiaodong | Director | 06/22/2020 | 906,673 |
| OYLER JOHN | Chief Executive Officer | 06/10/2020 | 157,563 |
| Liang Howard | CFO & Chief Strategy Officer | 06/08/2020 | 77,391 |
| Wu Xiaobin | President & GM China | 06/08/2020 | 478,317 |
| Huang Jane | CMO, Hematology | 06/08/2020 | 107,800 |
| Wang Xiaodong | Director | 06/08/2020 | 1,025,456 |
| Huang Jane | CMO, Hematology | 05/29/2020 | 44,235 |
| Huang Jane | CMO, Hematology | 05/29/2020 | 245,784 |
| Glazer Donald W. | Director | 05/19/2020 | 1,698,400 |
| OYLER JOHN | Chief Executive Officer | 05/01/2020 | 655,538 |
| Wu Xiaobin | President & GM China | 05/01/2020 | 992,711 |
| Huang Jane | CMO, Hematology | 04/29/2020 | 44,235 |
| Huang Jane | CMO, Hematology | 04/29/2020 | 243,450 |
| Huang Jane | CMO, Hematology | 04/16/2020 | 44,235 |
| Huang Jane | CMO, Hematology | 04/16/2020 | 240,000 |
| Wang Xiaodong | Director | 03/04/2020 | 785,682 |
| Huang Jane | CMO, Hematology | 02/18/2020 | 44,235 |
| Huang Jane | CMO, Hematology | 02/18/2020 | 255,380 |
| Huang Jane | CMO, Hematology | 01/21/2020 | 44,235 |
| Huang Jane | CMO, Hematology | 01/21/2020 | 256,043 |
| OYLER JOHN | Chief Executive Officer | 12/17/2019 | 10,000,110 |
| Huang Jane | CMO, Hematology | 12/16/2019 | 44,235 |
| Huang Jane | CMO, Hematology | 12/16/2019 | 247,711 |
| Liang Howard | CFO & Chief Strategy Officer | 11/18/2019 | 162,500 |
| Liang Howard | CFO & Chief Strategy Officer | 11/18/2019 | 4,858,612 |
| Huang Jane | CMO, Hematology | 11/18/2019 | 44,235 |
| Huang Jane | CMO, Hematology | 11/18/2019 | 291,740 |
| Wang Xiaodong | Director | 11/15/2019 | 79,810 |
| Wang Xiaodong | Director | 11/14/2019 | 504,242 |
| Wang Xiaodong | Director | 11/15/2019 | 302,267 |
| Wang Xiaodong | Director | 11/14/2019 | 1,643,881 |
| Wu Xiaobin | President & GM China | 11/15/2019 | 202,050 |
| Huang Jane | CMO, Hematology | 11/04/2019 | 970,221 |
| Huang Jane | CMO, Hematology | 11/04/2019 | 6,266,007 |
| Chen Timothy Yung-Cheng | Director | 11/05/2019 | 164,040 |
| Chen Timothy Yung-Cheng | Director | 11/04/2019 | 164,040 |
| Chen Timothy Yung-Cheng | Director | 11/05/2019 | 718,772 |
| Chen Timothy Yung-Cheng | Director | 11/04/2019 | 800,073 |
| Wang Xiaodong | Director | 11/04/2019 | 190,000 |
| Wang Xiaodong | Director | 11/01/2019 | 170,000 |
| Wu Xiaobin | President & GM China | 11/01/2019 | 180,000 |
| Huang Jane | CMO, Hematology | 09/04/2019 | 10,611 |
| Huang Jane | CMO, Hematology | 09/03/2019 | 413,419 |
| Chen Timothy Yung-Cheng | Director | 08/23/2019 | 249,561 |
| Chen Timothy Yung-Cheng | Director | 08/23/2019 | 1,248,682 |
| Huang Jane | CMO, Hematology | 08/12/2019 | 113,275 |
| Huang Jane | CMO, Hematology | 08/12/2019 | 336,855 |
| Huang Jane | CMO, Hematology | 07/29/2019 | 377,834 |
| Huang Jane | CMO, Hematology | 07/29/2019 | 1,362,896 |
| OYLER JOHN | Chief Executive Officer | 07/08/2019 | 394,056 |
| Huang Jane | CMO, Hematology | 06/27/2019 | 53,542 |
| Liang Howard | CFO & Chief Strategy Officer | 06/27/2019 | 55,653 |
| Wang Xiaodong | Director | 07/01/2019 | 612,938 |
| Huang Jane | CMO, Hematology | 05/21/2019 | 99,682 |
| Huang Jane | CMO, Hematology | 05/20/2019 | 13,593 |
| Huang Jane | CMO, Hematology | 05/21/2019 | 286,132 |
| Huang Jane | CMO, Hematology | 05/20/2019 | 39,036 |
| Liang Howard | CFO & Chief Strategy Officer | 05/21/2019 | 150,800 |
| Liang Howard | CFO & Chief Strategy Officer | 05/21/2019 | 3,020,872 |
| Glazer Donald W. | Director | 05/13/2019 | 1,880,028 |
| Liang Howard | CFO & Chief Strategy Officer | 05/06/2019 | 11,700 |
| Liang Howard | CFO & Chief Strategy Officer | 05/06/2019 | 234,014 |
| Wu Xiaobin | President & GM China | 05/01/2019 | 741,547 |
| OYLER JOHN | Chief Executive Officer | 05/01/2019 | 353,504 |
| Huang Jane | CMO, Hematology | 04/08/2019 | 416,694 |
| Huang Jane | CMO, Hematology | 04/08/2019 | 2,017,316 |
| Glazer Donald W. | Director | 03/14/2019 | 2,037,825 |
| Huang Jane | CMO, Hematology | 03/11/2019 | 75,642 |
| Huang Jane | CMO, Hematology | 03/11/2019 | 333,450 |
| Huang Jane | CMO, Hematology | 03/07/2019 | 9,976 |
| OYLER JOHN | Chief Executive Officer | 03/05/2019 | 729,432 |
| OYLER JOHN | Chief Executive Officer | 03/04/2019 | 697,425 |
| OYLER JOHN | Chief Executive Officer | 03/06/2019 | 15,000 |
| OYLER JOHN | Chief Executive Officer | 03/05/2019 | 945,455 |
| OYLER JOHN | Chief Executive Officer | 03/04/2019 | 1,481,625 |
| Wang Xiaodong | Director | 03/01/2019 | 150,000 |
| Wang Xiaodong | Director | 03/01/2019 | 584,125 |
| Peterson Amy C. | CMO, Immuno-oncology | 12/17/2018 | 286,897 |
| Peterson Amy C. | CMO, Immuno-oncology | 12/18/2018 | 295,103 |
| Peterson Amy C. | CMO, Immuno-oncology | 12/17/2018 | 1,317,225 |
| Peterson Amy C. | CMO, Immuno-oncology | 12/18/2018 | 1,356,312 |
| OYLER JOHN | Chief Executive Officer | 12/10/2018 | 561,863 |
| Wang Xiaodong | Director | 12/03/2018 | 762,060 |
| OYLER JOHN | Chief Executive Officer | 11/26/2018 | 1,262,428 |
| OYLER JOHN | Chief Executive Officer | 11/28/2018 | 1,304,863 |
| OYLER JOHN | Chief Executive Officer | 11/27/2018 | 1,626,741 |
| Huang Jane | CMO, Hematology | 11/26/2018 | 88,470 |
| Huang Jane | CMO, Hematology | 11/26/2018 | 418,749 |
| Wang Xiaodong | Director | 11/19/2018 | 621,489 |
| Peterson Amy C. | CMO, Immuno-oncology | 11/09/2018 | 384,760 |
| Peterson Amy C. | CMO, Immuno-oncology | 11/08/2018 | 428,090 |
| Peterson Amy C. | CMO, Immuno-oncology | 11/12/2018 | 351,150 |
| Peterson Amy C. | CMO, Immuno-oncology | 11/08/2018 | 1,854,578 |
| Peterson Amy C. | CMO, Immuno-oncology | 11/12/2018 | 1,360,348 |
| Peterson Amy C. | CMO, Immuno-oncology | 11/09/2018 | 1,593,163 |
| Huang Jane | CMO, Hematology | 09/04/2018 | 508,246 |
| Glazer Donald W. | Director | 08/30/2018 | 179,000 |
| Glazer Donald W. | Director | 08/29/2018 | 179,000 |
| Peterson Amy C. | CMO, Immuno-oncology | 08/23/2018 | 975,665 |
| Wang Xiaodong | Director | 08/13/2018 | 547,591 |
| BAKER BROS. ADVISORS LP | Director | 08/02/2018 | 627,922,800 |
| OYLER JOHN | Chief Executive Officer | 07/16/2018 | 418,498 |
| Liang Howard | CFO & Chief Strategy Officer | 03/16/2018 | 70,668 |
| Liang Howard | CFO & Chief Strategy Officer | 03/19/2018 | 156,832 |
| Liang Howard | CFO & Chief Strategy Officer | 03/19/2018 | 4,702,982 |
| Liang Howard | CFO & Chief Strategy Officer | 03/16/2018 | 1,707,669 |
| OYLER JOHN | Chief Executive Officer | 03/02/2018 | 3,756,785 |
| OYLER JOHN | Chief Executive Officer | 03/01/2018 | 5,623,203 |
| OYLER JOHN | Chief Executive Officer | 02/28/2018 | 5,036,940 |
| Li Ji | EVP and Gl. Head of Bus. Dev. | 02/28/2018 | 266,500 |
| Li Ji | EVP and Gl. Head of Bus. Dev. | 02/28/2018 | 1,468,761 |
| BAKER BROS. ADVISORS LP | Director | 01/18/2018 | 199,999,998 |
| OYLER JOHN | Chief Executive Officer | 12/26/2017 | 1,942,515 |
| Huang Jane | CMO, Hematology | 12/21/2017 | 29,510 |
| Huang Jane | CMO, Hematology | 12/21/2017 | 98,000 |
| Huang Jane | CMO, Hematology | 12/13/2017 | 44,265 |
| Huang Jane | CMO, Hematology | 12/13/2017 | 141,381 |
| OYLER JOHN | Chief Executive Officer | 12/07/2017 | 5,579,304 |
| OYLER JOHN | Chief Executive Officer | 12/06/2017 | 2,902,224 |
| OYLER JOHN | Chief Executive Officer | 12/08/2017 | 5,047,758 |
| Huang Jane | CMO, Hematology | 12/04/2017 | 94,600 |
| OYLER JOHN | Chief Executive Officer | 11/29/2017 | 3,013,458 |
| OYLER JOHN | Chief Executive Officer | 11/28/2017 | 2,820,864 |
| OYLER JOHN | Chief Executive Officer | 11/27/2017 | 1,438,582 |
| Huang Jane | CMO, Hematology | 11/16/2017 | 51,000 |
| Huang Jane | CMO, Hematology | 11/20/2017 | 87,000 |
| OYLER JOHN | Chief Executive Officer | 11/15/2017 | 5,300,508 |
| OYLER JOHN | Chief Executive Officer | 11/14/2017 | 4,770,950 |
| OYLER JOHN | Chief Executive Officer | 11/13/2017 | 2,080,916 |
| Peterson Amy C. | CMO, Immuno-oncology | 11/13/2017 | 298,747 |
| Peterson Amy C. | CMO, Immuno-oncology | 08/22/2017 | 151,830 |
| BAKER BROS. ADVISORS LP | Director | 08/11/2017 | 12,499,976 |
| Wang Xiaodong | Director | 07/12/2017 | 1,448,704 |
| Glazer Donald W. | Director | 07/10/2017 | 779,900 |
| OYLER JOHN | Chief Executive Officer | 07/06/2017 | 14,221,125 |
| Wang Xiaodong | Director | 06/28/2017 | 1,573,345 |
| OYLER JOHN | Chief Executive Officer | 06/22/2017 | 2,583,269 |
| OYLER JOHN | Chief Executive Officer | 06/23/2017 | 1,766,353 |
| Wang Xiaodong | Director | 06/02/2017 | 221,560 |
| Wang Xiaodong | Director | 05/04/2017 | 184,171 |
| Wang Xiaodong | Director | 05/03/2017 | 405,871 |
| OYLER JOHN | Chief Executive Officer | 05/01/2017 | 88,243 |
| OYLER JOHN | Chief Executive Officer | 04/27/2017 | 1,374,565 |
| Wang Xiaodong | Director | 04/05/2017 | 429,085 |
| Wang Xiaodong | Director | 03/24/2017 | 687,634 |
| Wang Xiaodong | Director | 03/23/2017 | 408,462 |
| Wang Xiaodong | Director | 03/22/2017 | 312,517 |
| OYLER JOHN | Chief Executive Officer | 03/20/2017 | 529,611 |
| OYLER JOHN | Chief Executive Officer | 03/17/2017 | 108,737 |
| OYLER JOHN | Chief Executive Officer | 03/16/2017 | 621,725 |
| Wang Xiaodong | Director | 03/10/2017 | 291,702 |
| Wang Xiaodong | Director | 03/09/2017 | 742,843 |
| Wang Xiaodong | Director | 03/08/2017 | 437,211 |
| OYLER JOHN | Chief Executive Officer | 03/06/2017 | 797,258 |
| OYLER JOHN | Chief Executive Officer | 03/03/2017 | 1,636,968 |
| OYLER JOHN | Chief Executive Officer | 03/02/2017 | 2,025,104 |
| Wang Xiaodong | Director | 02/24/2017 | 1,083,114 |
| Wang Xiaodong | Director | 02/23/2017 | 212,351 |
| Wang Xiaodong | Director | 02/27/2017 | 169,328 |
| OYLER JOHN | Chief Executive Officer | 02/21/2017 | 414,162 |
| OYLER JOHN | Chief Executive Officer | 02/17/2017 | 292,981 |
| OYLER JOHN | Chief Executive Officer | 02/16/2017 | 1,926,867 |
| Wang Xiaodong | Director | 11/23/2016 | 3,000,000 |
| Malley Thomas | Director | 11/23/2016 | 960,000 |
| BAKER BROS. ADVISORS LP | Director | 11/18/2016 | 56,335,840 |
| Glazer Donald W. | Director | 09/28/2016 | 1,271,175 |
| Glazer Donald W. | Director | 09/27/2016 | 784,691 |
| Glazer Donald W. | Director | 09/26/2016 | 611,300 |
| Glazer Donald W. | Director | 09/22/2016 | 778,561 |
| Glazer Donald W. | Director | 09/23/2016 | 351,793 |
| Glazer Donald W. | Director | 09/21/2016 | 508,958 |
| Glazer Donald W. | Director | 09/20/2016 | 255,615 |
| Glazer Donald W. | Director | 09/19/2016 | 1,348,487 |
| Liang Howard | CFO & Chief Strategy Officer | 02/08/2016 | 120,250 |
| Yuan RuiRong | Chief Medical Officer | 02/08/2016 | 240,500 |
| BAKER BROS. ADVISORS LP | Director | 02/08/2016 | 45,904,320 |
| BAKER BROS. ADVISORS LP | Director | 02/08/2016 | 1,750,000 |
Load More Insider Transactions
FUNDS WITH A POSITION IN BEIGENE LTD
| Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
|---|---|---|---|---|
| BAKER BROS. ADVISORS LP | 10,568,897 | 21.69% | -9.43% | Other |
| HHLR ADVISORS, LTD. | 5,176,906 | 18.82% | No change | Other |
| BLACKROCK INC. | 854,876 | 0.00393% | 6.1% | Other |
| GEODE CAPITAL MANAGEMENT, LLC | 35,725 | 0.00067% | -0.25% | Other |
| D. E. SHAW & CO., INC. | 2,727 | 0.00043% | New | Other |
CHANGE IN SHARES OUTSTANDING FOR BEIGENE LTD
STOCK BUYBACKS FOR BEIGENE LTD
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
Load More
Period of Report: 12/31/2023
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
09/30/2023
-2.69%
1Q
06/30/2023
-0.53%
2Q
03/31/2023
-0.09%
3Q
12/31/2022
0.29%
4Q
09/30/2022
0.57%
5Q
06/30/2022
1.23%
6Q
03/31/2022
1.57%
7Q
12/31/2021
9.49%
8Q
09/30/2021
12.19%
9Q
06/30/2021
13.31%
10Q
03/31/2021
7.59%
11Q
12/31/2020
14.49%
12Q
09/30/2020
17.75%
13Q
06/30/2020
33.93%
14Q
03/31/2020
34.58%
15Q
12/31/2019
71.48%
16Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR BEIGENE LTD
LOADING...